Diseases of oesophagus, stomach and duodenum

K11_OESSTODUO

gastric mucosal hypertrophy: MC)nC)trier disease (MD) is a rare premalignant hyperproliferative gastropathy characterized by massive overgrowth of foveolar cells in the gastric lining, resulting in large gastric folds, and manifesting with epigastric pain, nausea, vomiting, peripheral edema and, less commonly, anorexia and weight loss.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K20, K20#, K20-K31 Cause of death: ICD-10 — K20, K20#, K20-K31 2 out of 7 registries used, show all original rules.	74865
4. Check minimum number of events None	74865
5. Include endpoints K11_OESITIS K11_REFLUX K11_ACHAL K11_OESULC K11_OESOBST K11_PERFOES K11_BARRET K11_OTHDISOES K11_DISOESINOTH K11_GASTRODUOULC K11_ACUTGASTR K11_ALCGASTR K11_CHRONGASTR K11_OTHGASTR K11_FUNCDYSP K11_OTHDISSTOMDUOD	79323
6. Filter based on genotype QC (FinnGen only)	79323

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	K11_OESSTODUO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_OESITIS\|K11_REFLUX\|K11_ACHAL\|K11_OESULC\|K11_OESOBST\|K11_PERFOES\|K11_BARRET\|K11_OTHDISOES\|K11_DISOESINOTH\|K11_GASTRODUOULC\|K11_ACUTGASTR\|K11_ALCGASTR\|K11_CHRONGASTR\|K11_OTHGASTR\|K11_FUNCDYSP\|K11_OTHDISSTOMDUOD
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K2\|K3[0-1]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K2\|K3[0-1]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of oesophagus, stomach and duodenum based on the number of shared cases.

Similar with more cases:

Gastrointestinal diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	623888	321728	296006
Only index persons	515264	276763	238501
Unadjusted period prevalence (%)
Whole population	8.74	9.22	8.27
Only index persons	9.68	10.17	9.10
Median age at first event (years)
Whole population	58.01	59.54	56.27
Only index persons	56.26	57.62	54.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	79323	43480	35843
Unadjusted period prevalence (%)	15.26	14.82	15.80
Median age at first event (years)	57.03	55.11	59.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
28266: Matched controls
208248

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02AX02

ATC

tramadol; systemic, rectal

2.3

323.0

11557

48458

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.5

323.0

3656

11683

M01AH05

ATC

etoricoxib; oral

1.7

323.0

16413

94165

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

323.0

2838

7919

N06AX11

ATC

mirtazapine; oral

2.0

323.0

8897

39461

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

5.6

323.0

2266

3182

R51.80

ICD-10 Finland

Headache

2.2

323.0

4916

18008

N02BE01

ATC

paracetamol; systemic, rectal

2.2

323.0

23221

139912

K29.6

ICD-10 Finland

Other gastritis

42.7

323.0

479

M25.5

ICD-10 Finland

Pain in joint

1.8

323.0

8060

37217

N06AB04

ATC

citalopram; systemic

2.0

323.0

5882

24529

C03CA01

ATC

furosemide; systemic

2.5

323.0

3495

11061

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

84.7

323.0

1116

101

K22.7

ICD-10 Finland

Barrett oesophagus

85.1

323.0

555

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

323.0

5109

18997

K30

ICD-10 Finland

Functional dyspepsia

13.4

323.0

7102

5092

A02BC04

ATC

rabeprazole; oral

4.5

323.0

3633

6569

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

9196

42539

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

9515

44607

K29.1

ICD-10 Finland

Other acute gastritis

38.4

323.0

776

153

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

180.6

323.0

1421

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

323.0

5059

20146

A02BC01

ATC

omeprazole; systemic

3.5

323.0

8881

24105

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

323.0

7155

29753

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

73.8

323.0

8315

1169

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

323.0

12781

45940

R06.0

ICD-10 Finland

Dyspnoea

2.4

323.0

5702

19894

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

55.8

323.0

8765

1662

M03BX02

ATC

tizanidine; oral

1.8

323.0

18298

106553

K29.8

ICD-10 Finland

Duodenitis

207.0

323.0

414

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

323.0

5736

22202

UJF30

NOMESCO Finland

Ileoscopy through colon

3.7

323.0

3115

6828

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.3

323.0

2144

5088

N03AX16

ATC

pregabalin; oral

2.4

323.0

6499

23058

AA1AD

NOMESCO Finland

CT of head and brain

2.2

323.0

4463

16613

R03AC02

ATC

salbutamol; inhalant

1.9

323.0

15234

79774

K22.1

ICD-10 Finland

Ulcer of oesophagus

271.8

323.0

688

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.7

323.0

6251

14726

A02BC03

ATC

lansoprazole; oral

3.7

323.0

9829

26014

J01DB01

ATC

cefalexin; oral

1.8

323.0

22575

143579

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

342.2

323.0

638

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

23.6

323.0

18149

14678

K29.7

ICD-10 Finland

Gastritis, unspecified

33.2

323.0

2021

481

K29.4

ICD-10 Finland

Chronic atrophic gastritis

62.2

323.0

546

UJD02

NOMESCO Finland

Gastroscopy

11.2

323.0

1982

1387

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.4

323.0

2071

4677

J01MA02

ATC

ciprofloxacin; systemic

1.9

323.0

9053

42102

H02AB06

ATC

prednisolone; systemic

2.0

323.0

12334

58167

A02BA02

ATC

ranitidine; systemic

3.8

323.0

5971

13550

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

323.0

5170

19699

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

323.0

6528

21833

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

323.0

6985

30291

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

323.0

9426

45845

A02BC05

ATC

esomeprazole; systemic

4.6

323.0

15716

44241

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.7

323.0

2751

7934

UJF32

NOMESCO Finland

Coloscopy

3.7

323.0

7493

18530

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.3

323.0

2792

6696

R11

ICD-10 Finland

Nausea and vomiting

3.1

323.0

2342

5877

J01MA12

ATC

levofloxacin; systemic

2.2

323.0

3971

14436

N06AX21

ATC

duloxetine; oral

2.5

323.0

3554

11331

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

13.5

323.0

3184

1937

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.4

323.0

1772

3966

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

323.0

12541

65203

C07AB07

ATC

bisoprolol; oral

2.1

323.0

8702

36938

K92.0

ICD-10 Finland

Haematemesis

9.9

323.0

878

669

R13

ICD-10 Finland

Dysphagia

4.8

323.0

1752

2807

A03FA02

ATC

cisapride; oral, rectal

4.1

323.0

1930

3631

J01AA02

ATC

doxycycline; systemic

1.9

323.0

20892

125304

R12

ICD-10 Finland

Heartburn

3.9

323.0

2480

4992

G44.2

ICD-10 Finland

Tension-type headache

2.2

323.0

4113

14798

A02BC02

ATC

pantoprazole; systemic

4.8

323.0

21471

83129

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

323.0

5960

19455

WX002

NOMESCO Finland

Sedation and analgesia

2.3

323.0

4507

15657

K29.3

ICD-10 Finland

Chronic superficial gastritis

117.5

323.0

1510

100

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

323.0

4619

16669

P01AB01

ATC

metronidazole; oral, rectal

1.8

323.0

11101

54174

K20

ICD-10 Finland

Oesophagitis

28.5

323.0

803

213

N03AX12

ATC

gabapentin; oral

2.5

323.0

4270

13901

N05CF01

ATC

zopiclone; oral

1.9

323.0

7215

31624

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

323.0

6296

21921

N05BA04

ATC

oxazepam; oral

1.9

323.0

6503

28034

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.9

323.0

3870

10915

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

323.0

10073

39817

R42

ICD-10 Finland

Dizziness and giddiness

2.1

319.9

4329

16452

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

54.6

319.0

423

D64.9

ICD-10 Finland

Anaemia, unspecified

3.5

315.1

1697

3768

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

312.3

2906

9217

R53

ICD-10 Finland

Malaise and fatigue

2.0

312.1

5074

20755

G47.3

ICD-10 Finland

Sleep apnoea

1.9

308.5

5647

24136

N06AX16

ATC

venlafaxine; oral

2.0

303.5

4591

18230

A06AD11

ATC

lactulose; oral

2.6

301.4

2477

7320

C07AA05

ATC

propranolol; systemic

1.9

301.4

5651

24333

N05AH04

ATC

quetiapine; oral

1.9

300.3

5228

21907

J02AC01

ATC

fluconazole; systemic

1.6

299.0

11473

61479

K92.1

ICD-10 Finland

Melaena

5.0

296.5

1070

1630

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

4.1

293.5

1276

2352

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

291.4

15716

91705

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

290.0

7359

34964

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

287.5

10091

52617

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

286.4

10784

57289

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

3.7

283.1

1410

2931

A02BA04

ATC

nizatidine; systemic

3.2

283.1

1668

3957

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

280.5

5454

23705

D02

ICPC

Abdominal pain epigastric

3.2

278.5

1680

4055

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

276.8

4304

17211

XJC10

NOMESCO Finland

Oesophageal pH monitoring

44.6

270.6

371

UJF92

NOMESCO Finland

Capsular endoscopy

5.8

270.3

855

1113

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

269.9

5667

25238

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

157.4

268.4

317

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

1116.5

268.2

295

S18

ICPC

Laceration/cut

1.7

267.7

8629

43733

M01AH01

ATC

celecoxib; oral (coxibs)

2.0

266.0

3903

15228

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

264.7

3735

14337

N06AA09

ATC

amitriptyline; systemic

2.6

264.0

2195

6509

M01AE02

ATC

naproxen; oral, rectal

1.6

263.4

15588

91953

C10AA01

ATC

simvastatin; oral

1.8

262.8

5243

22923

M01AB05

ATC

diclofenac; systemic, rectal

1.6

262.2

17904

109252

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.3

261.9

2746

9215

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

261.8

8769

44845

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

261.2

1801

4759

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

260.2

4096

16421

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

257.7

4450

18468

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

257.6

13973

80542

WX110

NOMESCO Finland

Local anesthesy

1.6

256.2

19308

120293

N05BA01

ATC

diazepam; systemic, rectal

2.1

256.1

3239

11855

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

185.6

256.0

299

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

185.6

256.0

299

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.0

252.0

1121

2106

L03

ICPC

Low back symptom/complaint

1.8

252.0

5861

26896

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

251.9

4224

17324

R05

ICD-10 Finland

Cough

1.9

251.2

4325

17912

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.4

251.1

2504

8184

C08CA01

ATC

amlodipine; oral

1.8

247.3

5256

23405

H02AB04

ATC

methylprednisolone; systemic

2.0

247.0

3521

13542

J01FF01

ATC

clindamycin; systemic

1.7

246.7

6793

32769

K22.2

ICD-10 Finland

Oesophageal obstruction

145.4

246.6

293

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

245.7

6498

30974

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

343.5

245.5

278

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

245.3

7876

39657

R01AD09

ATC

mometasone; nasal

1.5

244.3

12763

72553

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

243.4

3021

10950

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

1916.5

242.6

265

R07.3

ICD-10 Finland

Other chest pain

2.5

240.9

2108

6419

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

161.4

239.2

282

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

8.2

237.7

589

538

SPAT1263

SPAT

Sampling

1.6

236.8

10159

54971

XF402

NOMESCO Finland

ECG with work load test

2.6

236.2

1940

5698

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

235.1

2506

8452

N02AA05

ATC

oxycodone; systemic

2.4

233.9

2265

7279

UKC02

NOMESCO Finland

Cystoscopy

2.3

231.3

2396

7965

M01AC06

ATC

meloxicam; systemic, rectal

1.6

230.4

8447

43879

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

230.0

3424

13371

R03DC03

ATC

montelukast; oral

1.8

228.6

4503

19487

N06AB10

ATC

escitalopram; oral

1.7

228.5

6255

30005

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

227.7

2613

9120

R01AD08

ATC

fluticasone; nasal

1.6

227.3

7964

40856

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

227.2

3096

11658

B03BA03

ATC

hydroxocobalamin; parenteral

4.1

227.0

993

1835

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

226.7

14136

83076

J01FA09

ATC

clarithromycin; systemic

1.6

224.7

8684

45645

J01FA06

ATC

roxithromycin; oral

1.5

224.2

10099

55076

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.5

223.9

2075

6511

M79.1

ICD-10 Finland

Myalgia

2.0

223.4

3492

13887

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.0

223.1

1484

3818

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

223.1

2226

7257

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

222.9

1868

5543

R03BA05

ATC

fluticasone; inhalant

1.8

222.7

4779

21258

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

220.9

239

C07AB02

ATC

metoprolol; systemic

2.1

220.7

2876

10619

D03

ICPC

Heartburn

4.2

220.0

945

1716

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

218.7

20209

129058

D01

ICPC

Abdominal pain/cramps general

2.1

218.6

2888

10722

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

218.2

3764

15523

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

216.6

4512

19855

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

213.3

5894

28261

N05CD07

ATC

temazepam; oral

2.4

213.0

2060

6603

J01DA01

ATC

[U] cefalexin; systemic

1.5

209.7

16518

101287

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

226.2

209.6

242

R03BB04

ATC

tiotropium bromide; inhalant

2.8

209.3

1535

4203

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

209.1

8107

42464

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

35.3

208.5

299

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

208.0

3060

11858

R4110

NOMESCO Finland

Physiotherapy

1.7

206.8

5814

27977

H02AB07

ATC

prednisone; oral

2.0

206.6

3132

12281

SPAT1153

SPAT

Removal of sutures

1.7

206.0

6000

29152

C10AA05

ATC

atorvastatin; oral

1.7

205.3

5431

25675

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

203.2

5096

23708

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

200.7

1937

6195

A02BX02

ATC

sucralfate; oral

4.2

200.7

855

1539

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.9

199.5

471

396

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

196.0

13694

81365

M02AA07

ATC

piroxicam; topical

1.6

194.9

7384

38316

J37.0

ICD-10 Finland

Chronic laryngitis

4.0

194.9

880

1672

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

193.5

7966

42153

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

193.5

2894

11269

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

193.0

3815

16435

B01AB05

ATC

enoxaparin; parenteral

1.6

191.9

5589

27070

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

190.7

3897

16969

G04CA02

ATC

tamsulosin; oral

2.1

190.1

2558

9537

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

189.4

981

2096

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

189.0

2201

7704

M01AX17

ATC

nimesulide; oral

1.7

187.9

4587

21106

L17

ICPC

Foot/toe symptom/complaint

1.7

186.4

5024

23788

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

185.3

10636

60426

R02

ICPC

Shortness of breath/dyspnoea

2.1

184.8

2331

8450

N06AB03

ATC

fluoxetine; oral

1.9

184.2

3235

13359

L08

ICPC

Shoulder symptom/complaint

1.8

183.6

3842

16838

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

183.4

2162

7603

L01

ICPC

Neck symptom/complaint

1.9

183.3

3291

13694

A02BDXX

ATC

4.9

180.6

658

1009

N05CF02

ATC

zolpidem; oral

1.7

180.1

4530

20999

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

178.8

5114

24579

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

178.0

2470

9312

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

178.0

2091

7339

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

177.5

2546

9730

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

176.8

4417

20423

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

176.4

14568

88662

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

16.1

176.4

316

146

J01FA10

ATC

azithromycin; systemic

1.4

176.2

16558

103305

A01

ICPC

Pain general/multiple sites

2.4

175.6

1657

5225

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

175.0

6439

33007

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

174.4

8292

45092

A07EA06

ATC

budesonide; oral, local oral

3.1

174.1

1061

2562

ZX120

NOMESCO Finland

Intravenous

2.2

173.6

2017

7041

K22.0

ICD-10 Finland

Achalasia of cardia

1356.3

173.3

190

T90

ICPC

Diabetes non-insulin dependent

1.8

173.1

3486

15063

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

172.9

2872

11604

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

172.6

1458

4329

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

171.9

1013

2387

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

171.1

7437

39602

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

171.0

4657

22048

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

170.6

3252

13788

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

170.2

4244

19589

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.7

169.9

1300

3643

C10AC01

ATC

colestyramine; oral

4.1

169.6

730

1326

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

169.3

2987

12327

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.4

168.9

1621

5154

R03BA02

ATC

budesonide; inhalant

1.7

167.7

4292

19952

R06AE07

ATC

cetirizine; oral

1.4

167.5

11571

67773

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

167.3

5251

25815

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

164.5

896

1990

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

+∞

164.4

178

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

164.3

2458

9536

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

164.0

16292

101989

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

163.7

3164

13465

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

162.8

2183

8101

C09CA06

ATC

candesartan; oral

1.7

162.3

4516

21472

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.8

162.0

1176

3190

XJC00

NOMESCO Finland

Oesophageal manometry

62.4

161.9

210

A02BA03

ATC

famotidine; systemic

3.9

161.4

731

1391

B81

ICPC

Anaemia vit B12/folate deficiency

4.8

159.5

587

910

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

159.5

2450

9598

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

159.3

11121

65055

K59.1

ICD-10 Finland

Functional diarrhoea

2.8

159.1

1131

3026

E66.8

ICD-10 Finland

Other obesity

2.3

158.2

1721

5817

K02.1

ICD-10 Finland

Caries of dentine

1.4

157.9

16224

101832

SPAT1097

SPAT

Recording of ECG

2.0

157.6

2244

8531

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

157.6

1855

6504

ZXA00

NOMESCO Finland

Right side

1.6

157.5

4841

23618

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

157.4

1572

5096

5350A

ICD-9 Finland

Gastritis and duodenitis, Acute gastritis

+∞

157.0

170

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

156.8

7728

42131

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

156.2

2420

9504

M01AH02

ATC

rofecoxib; oral

2.0

156.0

2175

8195

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

155.6

3055

13055

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

155.4

990

2462

R52.9

ICD-10 Finland

Pain, unspecified

2.1

155.4

1912

6834

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

155.2

1517

4864

R50.9

ICD-10 Finland

Fever, unspecified

1.8

155.0

3201

13905

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.2

155.0

1712

5827

XQ800

NOMESCO Finland

Prick test

2.0

154.9

2324

9016

N05BA12

ATC

alprazolam; oral

1.9

154.9

2444

9666

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

154.8

6253

32607

J01CA04

ATC

amoxicillin; systemic

1.5

154.4

22211

148265

SPAT1301

SPAT

No procedures

1.5

154.3

6265

32701

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

34.9

153.9

221

R00.2

ICD-10 Finland

Palpitations

2.2

153.8

1794

6262

K29.2

ICD-10 Finland

Alcoholic gastritis

79.5

153.6

193

M79.7

ICD-10 Finland

Fibromyalgia

2.9

153.4

1047

2729

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

153.0

2485

9930

SPAT1262

SPAT

Handing over of treatment supplies

1.8

152.6

3168

13779

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.3

152.1

1580

5221

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

151.7

2005

7388

L04AX01

ATC

azathioprine; systemic

2.5

151.4

1291

3848

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

150.9

2720

11284

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

150.8

6851

36633

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

150.8

2639

10835

A07AA02

ATC

nystatin; oral

2.8

150.4

1111

3044

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

184.3

149.1

174

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

148.5

946

2353

R05FB02

ATC

cough suppressants and expectorants

1.5

147.6

7828

43210

M54.2

ICD-10 Finland

Cervicalgia

2.1

147.5

1849

6659

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

147.0

1446

4647

R03BA08

ATC

ciclesonide; inhalant

2.0

146.7

2075

7857

ZXA05

NOMESCO Finland

Left side

1.6

146.4

4481

21788

A10BA02

ATC

metformin; oral

1.6

146.2

4243

20344

N06AB06

ATC

sertraline; oral

1.8

146.1

3103

13583

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

145.7

1233

3657

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

145.6

5835

30297

H03AA01

ATC

levothyroxine sodium; systemic

1.6

145.2

4756

23522

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

145.2

2592

10705

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

145.1

1859

6755

C03DA01

ATC

spironolactone; oral

2.3

144.5

1507

4987

205

Kela drug reimbursment

Chronic hypertension

1.8

144.3

3009

13092

WX290

NOMESCO Finland

Other blockade of nerve

1.4

144.2

13526

82907

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.0

143.2

629

1164

A07EC02

ATC

mesalazine; oral, rectal

2.2

142.0

1568

5331

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.4

141.6

1391

4467

C05AA08

ATC

fluocortolone; rectal, topical

1.7

140.6

3110

13773

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

140.1

2008

7635

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

139.9

3884

18375

L28

ICPC

Limited function/disability (L)

2.0

139.9

2060

7920

JAH01

NOMESCO Finland

Laparoscopy

2.4

139.6

1327

4190

SPAT1254

SPAT

Administration of medicine

1.8

138.9

2644

11154

Z01.2

ICD-10 Finland

Dental examination

1.4

138.9

10923

64759

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

138.2

1231

3755

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

137.9

1560

5360

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

72.1

137.7

175

R07.0

ICD-10 Finland

Pain in throat

2.1

137.1

1739

6288

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.5

137.1

1168

3477

R05

ICPC

Cough

1.6

136.7

4841

24363

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

136.6

2060

7989

WX892

NOMESCO Finland

Monitored bed care

2.3

136.6

1428

4726

M01AB55

ATC

diclofenac, combinations; oral

2.6

136.3

1106

3201

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

136.2

1398

4587

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

135.9

1770

6469

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

135.7

1857

6928

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

1123.6

135.5

149

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

135.0

2022

7818

N03AE01

ATC

clonazepam; systemic

2.3

134.7

1355

4401

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

134.5

1425

4747

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

134.5

973

2630

R01AD12

ATC

fluticasone furoate; nasal

1.4

134.4

8505

48384

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

6.9

134.4

372

404

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.8

133.6

2480

10365

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

133.2

1925

7339

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

133.1

3329

15274

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

132.7

2203

8852

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

132.5

1568

5495

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

132.0

2843

12473

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

117.8

131.8

159

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

35.7

131.7

188

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

131.7

1675

6060

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.5

131.1

694

1506

XKD00

NOMESCO Finland

Uroflowmetry

2.0

131.1

1793

6685

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

131.1

1809

6769

A01AB09

ATC

miconazole; local oral

2.1

130.3

1682

6124

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

130.2

6517

35364

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

129.7

1296

4194

R96

ICPC

Asthma

2.1

129.7

1709

6274

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

129.4

1243

3941

D07AC01

ATC

betamethasone; topical

1.4

129.3

7409

41285

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

129.3

1869

7125

A09AA02

ATC

multienzymes (lipase, protease etc.)

5.2

128.9

441

630

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

128.4

1426

4856

D06

ICPC

Abdominal pain localized other

2.0

128.1

1842

7007

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

126.3

4578

23114

N03AX09

ATC

lamotrigine; oral

2.1

126.2

1579

5669

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

126.1

4322

21528

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

126.1

1830

6985

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

125.8

1491

5227

5355X

ICD-9 Finland

Gastritis and duodenitis, Unspecified gastritis and gastroduodenitis

+∞

125.6

136

A06AC51

ATC

ispaghula, combinations; systemic

2.6

125.4

1030

3000

A11

ICPC

Chest pain NOS

2.4

125.1

1234

3965

C01DA14

ATC

isosorbide mononitrate; oral

2.7

125.1

980

2779

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

125.0

7291

40713

N07BB01

ATC

disulfiram; oral

2.2

124.8

1420

4887

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.6

124.6

618

1272

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

124.5

1439

4988

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.6

123.9

996

2866

SPAT1260

SPAT

Consultation of another employee

1.6

123.9

3403

16006

SPAT1310

SPAT

Counselling related to known health issue

1.4

123.8

6672

36675

S06.0

ICD-10 Finland

Concussion

1.8

123.6

2423

10300

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

68.4

122.7

157

D11

ICPC

Diarrhoea

1.7

122.4

3044

13920

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

122.4

1127

3496

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

122.0

1546

5580

R52.2

ICD-10 Finland

Other chronic pain

2.9

122.0

832

2165

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.0

121.7

432

644

WX402

NOMESCO Finland

General anaesthesia

1.6

121.7

4002

19718

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

120.5

2436

10456

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

120.0

2018

8135

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.4

119.7

651

1443

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

119.0

1886

7439

107

Kela drug reimbursment

Pernicious anaemia

6.4

118.9

344

398

N06AX12

ATC

bupropion; oral

1.9

118.6

2098

8609

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

118.5

1731

6619

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.8

118.4

554

1085

L13

ICPC

Hip symptom/complaint

1.8

117.6

2157

8959

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

117.4

1499

5425

J01MA14

ATC

moxifloxacin; systemic

2.0

117.4

1799

7004

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

117.3

858

2332

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

6.2

116.7

345

411

K59.0

ICD-10 Finland

Constipation

2.6

116.6

935

2686

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

116.6

1531

5606

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

116.4

2044

8364

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

116.3

1118

3545

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

116.3

1909

7627

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

116.1

10367

62183

ZXA10

NOMESCO Finland

Bilateral

1.6

115.6

3201

15065

H04.10

ICD-10 Finland

Dry eye syndrome

1.9

115.5

2017

8234

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.6

115.2

3142

14725

R60.0

ICD-10 Finland

Localized oedema

2.0

114.9

1657

6301

R06.5

ICD-10 Finland

Mouth breathing

1.8

114.8

2154

9015

XG410

NOMESCO Finland

Flow-volume spirometry

2.8

113.6

826

2238

R10.0

ICD-10 Finland

Acute abdomen

2.8

113.6

828

2245

J45

ICD-10 Finland

Asthma

1.8

113.4

2205

9336

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

113.4

1603

6048

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

113.3

2745

12441

R03AC03

ATC

terbutaline; inhalant

1.6

113.1

3279

15614

C09CA01

ATC

losartan; oral

1.6

113.0

3575

17413

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.2

112.6

1249

4244

L02

ICPC

Back symptom/complaint

1.8

111.8

2161

9130

C09AA02

ATC

enalapril; systemic

1.7

111.6

2457

10818

J20

ICD-10 Finland

Acute bronchitis

1.8

111.0

2022

8375

L15

ICPC

Knee symptom/complaint

1.6

110.9

3748

18548

R55

ICD-10 Finland

Syncope and collapse

2.0

110.2

1642

6321

SPAT1104

SPAT

Monitoring of emergency patient

2.2

109.9

1209

4091

J01EA01

ATC

trimethoprim; systemic

1.5

109.8

4924

25971

WZA90

NOMESCO Finland

Other doctors statement

1.5

109.7

5489

29610

JN4BD

NOMESCO Finland

Extensive body CT

2.0

109.7

1580

6002

K50.8

ICD-10 Finland

Other Crohn disease

3.5

109.2

571

1227

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

109.1

8772

51569

N04BC05

ATC

pramipexole; oral

2.3

108.7

1144

3790

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.1

108.5

666

1613

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

108.4

755

1988

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

108.1

5784

31603

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

108.0

1074

3462

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.7

107.2

525

1069

M01AX05

ATC

glucosamine; oral

1.9

107.0

1864

7597

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.9

107.0

1658

6478

R4190

NOMESCO Finland

Nutritional therapy

2.5

106.8

955

2913

N06AA12

ATC

doxepin; systemic

2.4

106.7

975

3008

E0000UV

ATC

1.4

106.3

9162

54416

C10AA07

ATC

rosuvastatin; oral

1.6

106.2

3489

17132

A28

ICPC

Limited function/disability NOS

2.1

106.0

1315

4696

C09AA05

ATC

ramipril; oral

1.6

106.0

2975

14028

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.4

105.9

573

1265

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

105.5

1621

6309

WX704

NOMESCO Finland

Intubation

1.9

105.3

1627

6346

SPAT1058

SPAT

PEF monitoring instruction

2.0

104.5

1448

5413

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

116.5

104.5

126

6241

FHL

Fund application (Nissen)

116.5

104.5

126

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

104.3

1134

3816

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

104.3

1465

5507

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

104.1

2096

8963

M02AA10

ATC

ketoprofen; topical

1.6

103.9

3016

14345

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

103.8

4798

25430

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.9

103.6

1811

7387

N03AG01

ATC

valproic acid; systemic, rectal

1.9

103.1

1599

6245

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

103.0

1813

7411

WZC30

NOMESCO Finland

Teaching

1.7

102.3

2502

11348

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

101.8

1203

4203

R06AX27

ATC

desloratadine; oral

1.4

101.8

7555

43705

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

101.5

6770

38445

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.6

101.5

512

1069

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

101.3

2279

10085

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

4.2

101.3

428

764

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

101.2

1230

4351

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

100.8

2948

14039

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

100.6

1002

3230

N06AX03

ATC

mianserin; oral

2.4

100.4

964

3051

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

100.2

549

1224

JAH00

NOMESCO Finland

Laparotomy

3.3

100.0

549

1226

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

99.8

4744

25264

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

99.3

6554

37119

A04

ICPC

Weakness/tiredness general

1.7

99.3

2463

11210

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

99.2

3478

17321

R03AC12

ATC

salmeterol; inhalant

2.6

98.9

782

2225

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

98.2

807

2348

M48.0

ICD-10 Finland

Spinal stenosis

2.0

98.1

1321

4879

SPAT1240

SPAT

Therapeutic discussion

1.6

98.0

3109

15109

B01AC04

ATC

clopidogrel; oral

2.0

97.8

1389

5241

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.6

97.2

491

1026

K25.1

ICD-10 Finland

Gastric ulcer, Acute with perforation

+∞

96.9

105

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

96.9

8723

51954

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

96.9

818

2418

N30.0

ICD-10 Finland

Acute cystitis

1.7

96.7

2469

11329

X58

ICD-10 Finland

Exposure to other specified factors

1.5

96.5

3458

17299

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

96.4

1064

3602

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

8.7

96.4

229

196

N05AA02

ATC

levomepromazine; systemic

2.3

95.9

1029

3437

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

95.9

1298

4805

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

5.6

95.7

307

407

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

95.6

866

2658

B02AA02

ATC

tranexamic acid; systemic

1.5

95.5

3689

18772

TK800

NOMESCO Finland

Hemodialysis

3.5

95.1

489

1037

R35

ICD-10 Finland

Polyuria

2.3

95.0

952

3078

127

Kela drug reimbursment

Transplant complication

3.7

95.0

466

951

A10AE04

ATC

insulin glargine; parenteral

1.8

94.9

1726

7131

L04AA06

ATC

mycophenolic acid; systemic

3.4

94.7

505

1103

M54.3

ICD-10 Finland

Sciatica

2.1

94.6

1254

4600

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

94.6

1942

8349

R49.01

ICD-10 Finland

Functional dysphonia

2.7

94.4

693

1888

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

94.4

867

2682

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

94.2

4016

20872

S22.3

ICD-10 Finland

Fracture of rib

2.1

94.1

1237

4523

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.8

93.9

441

867

L16

ICPC

Ankle symptom/complaint

1.7

93.9

2085

9183

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

93.7

2451

11314

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.7

93.6

2378

10892

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

7.2

93.4

248

254

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

93.3

2288

10373

UJC12

NOMESCO Finland

Flexible oesophagoscopy

10.2

93.2

203

148

LCA06

NOMESCO Finland

Biopsy of endometrium

1.6

93.1

2811

13478

AN1

Coronary angiography

2.2

93.1

1010

3393

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.8

93.1

645

1694

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.7

92.6

682

1861

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

92.6

2133

9495

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

92.5

17736

117346

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

92.0

1121

3967

K08.80

ICD-10 Finland

Toothache NOS

1.7

91.6

2154

9644

SPAT1312

SPAT

General health counselling

1.4

91.4

6932

40088

N05BA02

ATC

chlordiazepoxide; systemic

3.0

90.7

568

1393

XF404

NOMESCO Finland

Ambulatory ECG

1.9

90.3

1421

5574

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

90.0

1238

4610

Z50.1

ICD-10 Finland

Other physical therapy

2.2

90.0

1000

3397

M04AA01

ATC

allopurinol; systemic

2.0

89.9

1349

5199

N17

ICPC

Vertigo/dizziness

1.8

89.7

1650

6837

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

89.6

863

2734

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

+∞

89.5

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.6

89.4

448

931

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

89.3

1047

3642

P01BA02

ATC

hydroxychloroquine; oral

1.8

89.3

1609

6622

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.3

89.2

299

418

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

89.2

2001

8832

C01CA24

ATC

epinephrine; parenteral

1.8

89.0

1718

7234

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

88.8

828

2581

F10.24

ICD-10 Finland

Alcohol depence active use

3.3

88.7

492

1108

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.0

88.5

1294

4934

A10BH01

ATC

sitagliptin; oral

2.0

88.3

1221

4555

EBA00

NOMESCO Finland

Extraction of tooth

1.3

88.1

7751

45836

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

88.1

1224

4576

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

87.9

4637

25121

R03BA01

ATC

beclometasone; inhalant

1.6

87.6

2899

14209

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

87.3

2658

12760

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.7

87.1

644

1760

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.5

86.8

728

2144

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

86.6

2158

9818

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.3

86.6

925

3083

SPAT1255

SPAT

Intravenous administration of medicine

2.0

86.1

1164

4302

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.2

86.0

931

3121

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

86.0

1921

8465

R63.4

ICD-10 Finland

Abnormal weight loss

3.1

85.5

524

1268

C08CA05

ATC

nifedipine; systemic

2.2

85.5

942

3186

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

85.4

2568

12285

N01

ICPC

Headache

1.6

85.3

2698

13072

R33

ICD-10 Finland

Retention of urine

2.4

85.3

783

2422

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

85.2

1497

6106

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

85.1

1450

5849

G04CA01

ATC

alfuzosin; oral

1.9

85.0

1423

5704

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

84.8

1788

7740

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

84.7

1268

4878

S29

ICPC

Skin symptom/complaint other

1.6

84.6

2823

13854

P06

ICPC

Sleep disturbance

1.6

84.5

2304

10743

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

84.4

827

2644

M54

ICD-10 Finland

Dorsalgia

1.6

84.4

2688

13041

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

84.2

736

2217

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

83.9

2066

9363

K07.60

ICD-10 Finland

Snapping jaw

1.9

83.7

1376

5480

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7.9

83.4

209

196

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.3

83.3

885

2942

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

83.2

1469

6000

GD1AD

NOMESCO Finland

Thorax CT examination

2.6

82.8

674

1951

L12

ICPC

Hand/finger symptom/complaint

1.5

82.6

2929

14576

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

82.6

501

1203

K85

ICD-10 Finland

Acute pancreatitis

3.9

82.5

376

721

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

82.2

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

82.0

542

1380

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

81.9

868

2882

R74

ICPC

Upper respiratory infection acute

1.3

81.9

8110

48695

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

81.9

1098

4043

J01CA08

ATC

pivmecillinam; oral

1.3

81.3

8646

52432

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

+∞

81.2

N06AB05

ATC

paroxetine; oral

1.8

81.2

1565

6581

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.9

81.2

1382

5573

JN4AD

NOMESCO Finland

Body CT examination

2.1

81.1

1011

3613

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

81.1

1493

6185

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

81.0

1984

8974

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.3

80.6

329

569

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

80.2

508

1256

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.1

79.8

238

288

M54.1

ICD-10 Finland

Radiculopathy

2.2

79.8

863

2893

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.4

79.7

720

2207

P15

ICPC

Chronic alcohol abuse

2.3

79.7

800

2589

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.9

79.6

534

1375

K90.0

ICD-10 Finland

Coeliac disease

2.5

79.5

675

2001

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

79.5

1265

4979

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

79.2

2637

12921

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

78.9

963

3410

N06AA10

ATC

nortriptyline; systemic

2.8

78.8

551

1457

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

78.4

1150

4387

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.8

78.4

369

728

R03AC13

ATC

formoterol; inhalant

2.1

78.2

922

3216

J45.8

ICD-10 Finland

Mixed asthma

2.6

78.1

639

1856

C03AA03

ATC

hydrochlorothiazide; oral

2.1

78.0

970

3461

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

78.0

1379

5632

J01MA01

ATC

ofloxacin; systemic

1.8

77.9

1411

5812

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.9

77.8

527

1365

SPAT1229

SPAT

Assessment of need for aid

2.1

77.7

920

3214

R04.2

ICD-10 Finland

Haemoptysis

3.2

77.6

459

1084

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.4

77.6

744

2353

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

77.2

1498

6310

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

77.2

1519

6427

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

77.2

2933

14815

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

77.1

785

2557

J46

ICD-10 Finland

Status asthmaticus

2.7

77.0

582

1614

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

76.9

1148

4409

R51

ICD-10 Finland

Headache

1.9

76.9

1343

5461

Z71.8

ICD-10 Finland

Other specified counselling

1.4

76.6

5580

31896

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.0

76.4

481

1185

P03

ICPC

Feeling depressed

1.6

76.3

2551

12507

SPAT1216

SPAT

Assessment of functional ability

1.7

76.2

1727

7635

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

8.3

76.2

185

165

W78

ICPC

Pregnancy

0.7

76.0

2058

22290

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.8

75.9

1404

5821

Z00.0

ICD-10 Finland

General medical examination

1.5

75.8

3560

18794

R49.08

ICD-10 Finland

Other specified dysphonia

3.0

75.6

488

1224

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

75.5

24903

174875

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

75.5

1143

4413

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

75.3

2997

15289

ACC51

NOMESCO Finland

Release of median nerve

1.8

75.2

1568

6755

C08CA13

ATC

lercanidipine; oral

1.8

74.9

1477

6252

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

74.7

478

1192

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

74.7

6008

34864

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.8

74.5

535

1436

SPAT1197

SPAT

Extensive health check-up of expecting family

0.6

74.3

1809

20025

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

74.3

979

3577

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

74.2

1708

7582

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.3

73.8

406

909

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

73.7

2110

9948

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.2

73.5

855

2962

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

73.5

889

3134

J01MA06

ATC

norfloxacin; oral

1.5

73.4

2465

12092

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

73.4

870

3039

L86

ICPC

Back syndrome with radiating pain

2.0

73.4

1060

4021

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.2

73.2

860

2993

53508

ICD-8 Finland

Gastritis and duodenitis, Gastroduodenitis NUD

+∞

72.9

R06AX22

ATC

ebastine; oral

1.4

72.9

4263

23445

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

72.7

1307

5367

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

72.4

459

1138

B01AA03

ATC

warfarin; systemic

1.7

72.4

1705

7621

C10AX09

ATC

ezetimibe; oral

1.8

72.3

1357

5653

N05BE01

ATC

buspirone; oral

2.3

72.3

721

2324

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6253

22558

1.75

315.89

3.2

2.8

ng/l

207.1

200.4

0.46

5652

20473

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3571

10673

2.09

315.57

4.4

3.9

mmol/l

24.7

24.8

1.02

3335

9873

(3030467) Casts [#/volume] in Urine by Automated count

19093

82669

1.57

307.65

3.7

3.0

e6/l

0.4

2.68

14834

61387

(3026782) Osmolality of Urine

14147

57660

1.62

307.65

3.2

2.6

mosm/kgh2o

534.8

550.4

11.03

12124

49100

(3014111) Lactate [Moles/volume] in Serum or Plasma

6959

24687

1.80

307.65

7.9

6.9

mmol/l

1.4

1.3

1.39

6682

23768

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12376

52283

1.54

307.65

3.0

mmol/l

2.4

0.04

10612

45753

(3012544) pH of Venous blood

7635

26779

1.83

307.65

4.6

3.9

7.4

0.76

125

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12131

49866

1.58

307.65

1.3

u/ml

11.6

11.4

0.11

4344

20137

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7701

28075

1.75

307.65

3.5

4.1

ug/l

15.6

26.9

3.21

6137

22400

(3007566) Smooth muscle Ab [Titer] in Serum

2946

7690

2.39

307.65

1.3

1.2

titre

104.9

125.5

0.70

260

721

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11168

44439

1.63

307.65

2.3

2.1

29.9

29.8

1.58

10802

43166

(3042936) Bacteria identified in Isolate by Culture

10698

41589

1.67

307.65

2.4

1.9

—

(3002032) Base excess in Venous blood by calculation

7407

25755

1.84

307.65

4.7

3.9

mmol/l

1.8

1.9

0.73

6130

21015

(3019198) Lymphocytes [#/volume] in Blood

35998

157981

1.84

307.65

6.9

5.7

e9/l

1.9

0.98

32310

139218

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

9170

31560

1.89

307.65

3.8

4.3

u/l

238.1

244.4

2.34

8584

29949

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16988

66048

1.76

307.65

1.9

1.7

mg/l

1.1

1.2

0.98

12843

50194

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

14627

54751

1.80

307.65

4.4

3.4

ng/l

347.6

554.6

5.58

10937

40642

(3007853) Bacteria identified in Skin by Aerobe culture

9149

35412

1.66

307.65

2.0

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

21104

70162

2.21

307.65

2.7

2.1

mg/l

3.1

2.9

25.18

18316

59805

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8379

25533

2.14

307.65

2.7

2.2

g/l

0.2

6.88

7783

23752

(3006504) Eosinophils/100 leukocytes in Blood

33270

143495

1.82

307.65

7.0

5.9

2.9

0.76

31037

134082

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

27756

89269

2.53

307.65

3.2

2.4

u/l

57.4

58.2

0.86

25815

82275

(3037467) Urinalysis macro (dipstick) panel - Urine

44586

213622

1.82

307.65

5.3

4.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

928

471

12.12

307.65

1.1

1.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

35053

144964

1.99

307.65

8.2

6.3

mmol/l

1.2

7.87

29939

121881

(3012516) Albumin [Mass/volume] in Urine

18951

84701

1.50

307.65

3.5

3.2

mg/l

538.4

384.0

3.41

12173

53680

(4010399)

6036

20348

1.88

307.65

1.5

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

51406

235238

2.46

307.65

9.4

6.9

u/l

79.4

77.4

15.14

48924

221243

(3024561) Albumin [Mass/volume] in Serum or Plasma

31955

125878

2.05

307.65

6.0

4.5

g/l

35.4

35.7

22.54

29829

116594

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6590

23178

1.81

307.65

2.6

2.2

ug/l

6.4

7.6

4.57

5674

20194

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

55035

305961

1.54

307.65

5.2

4.2

mmol/l

6.0

5.9

104.65

50466

281623

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

47377

243681

1.63

307.65

4.6

3.9

pmol/l

14.8

14.7

14.95

43328

223157

(40758558) Short blood count panel - Blood

17918

76782

1.57

307.65

7.2

6.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

28713

123972

1.72

307.65

2.6

2.2

nmol/l

76.6

805.1

0.50

25850

112541

(3032080) INR in Blood by Coagulation assay

29153

116212

1.93

307.65

9.3

8.3

inr

1.2

2.94

7900

34774

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24526

100496

1.77

307.65

3.9

3.1

u/l

34.0

33.1

0.69

23246

95344

(3013650) Neutrophils [#/volume] in Blood by Automated count

39299

177653

1.84

307.65

9.8

8.9

e9/l

4.2

4.1

3.82

35033

154783

(3022145) Colonoscopy Study observation

10316

31403

2.18

307.65

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15264

60963

1.68

307.65

1.7

1.6

pmol/l

52496739.5

30178925.3

3.25

12839

50758

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

32192

130832

1.96

307.65

7.3

5.7

mmol/l

1.2

8.97

29294

118693

(3013707) Erythrocyte sedimentation rate by Westergren method

48644

229328

2.08

307.65

5.1

3.7

mm/h

12.6

11.5

52.04

45395

212885

(3019550) Sodium [Moles/volume] in Serum or Plasma

59221

325977

1.97

307.65

22.7

13.9

mmol/l

139.5

139.7

55.36

58116

317416

(3048689) Calprotectin [Mass/mass] in Stool

11741

35850

2.20

307.65

2.6

2.3

ug/g

138.0

130.4

1.13

9373

28156

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12342

45460

1.80

307.65

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6876

21420

2.06

307.65

2.7

g/l

10.6

0.04

6291

19610

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22365

87320

1.84

307.65

2.4

2.0

u/l

196.0

215.3

1.53

21114

81850

(3022313) Gas panel - Capillary blood

4013

12268

2.05

307.65

4.2

3.7

—

(36660697) Celiac disease serology panel - Serum

6727

23662

1.81

307.65

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

7213

21717

2.14

307.65

2.6

2.7

e9/l

71.1

69.3

3.12

5564

16129

(42870588) Differential panel, method unspecified - Blood

25949

101823

1.90

307.65

6.6

5.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7396

25885

1.83

307.65

4.6

3.9

kpa

5.8

1.35

7183

25116

(3001604) Monocytes [#/volume] in Blood

35275

152786

1.86

307.65

6.8

5.7

e9/l

0.6

5.58

31225

132136

(3023368) Bacteria identified in Blood by Culture

19599

77762

1.75

307.65

4.9

4.1

—

(3037522) Nuclear Ab [Titer] in Serum

11578

41117

1.86

307.65

1.4

1.3

titre

574.8

525.6

1.63

2525

7966

(3015736) pH of Urine

25398

118102

1.50

307.65

4.0

3.2

5.7

5.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

59292

327036

1.96

307.65

22.8

14.1

mmol/l

4.0

12.19

58096

317834

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13006

46015

1.89

307.65

3.9

3.4

mmol/l

0.8

26.17

12173

42867

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6843

19485

2.26

307.65

1.8

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18000

66685

1.88

307.65

1.4

1.3

u/ml

1.8

1.6

0.41

4474

18761

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8260

26295

2.04

307.65

3.1

2.3

u/l

44.7

44.9

0.01

7133

22490

(3013826) Glucose [Moles/volume] in Serum or Plasma

39841

176668

1.93

307.65

6.0

4.4

mmol/l

6.7

5.43

37792

163844

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

42681

215280

1.57

307.65

4.1

2.8

u/l

55.7

45.5

66.83

39983

202228

(3033658) Prothrombin time (PT) actual/Normal

18179

76475

1.61

307.65

5.3

3.7

90.2

91.1

4.19

17681

74510

(3018418) pH of Serum or Plasma

20582

86172

1.65

307.65

4.9

3.9

7.4

0.62

3725

16801

(3009343) pH of Capillary blood

5465

17180

2.02

307.65

4.0

3.6

7.4

0.39

644

2337

(3009508) Creatinine [Moles/volume] in Urine

20167

92769

1.46

307.65

3.5

3.2

mmol/l

7.4

8.0

3.40

16844

78547

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

31206

144562

1.59

307.65

4.7

3.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

5003

13575

2.34

307.65

2.5

2.3

—

(3018095) Leukocytes [#/volume] in Urine

23681

107078

1.53

307.65

4.4

3.5

e6/l

82.9

98.8

1.84

17659

74325

(3022217) INR in Platelet poor plasma by Coagulation assay

10069

35994

1.82

307.65

23.7

23.1

inr

1.3

0.26

1519

5093

(3013115) Eosinophils [#/volume] in Blood

36520

158503

1.89

307.65

7.1

6.0

e9/l

0.2

1.55

32634

139262

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

4650

9378

3.16

307.65

1.7

1.6

—

(3019225) pH of Specimen

8098

26609

1.97

307.65

4.6

4.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

9591

35279

1.76

307.65

8.4

6.9

mmol/l

104.3

104.5

6.12

9396

34495

(3024354) Oxygen [Partial pressure] in Venous blood

6040

21247

1.80

307.65

3.9

3.3

kpa

4.6

0.38

5833

20540

(3035350) Ketones [Presence] in Urine by Test strip

31420

152989

1.47

307.65

4.3

3.3

estimate

0.0

1.13

5417

29112

(3000570) Elastase.pancreatic [Mass/mass] in Stool

3476

7041

3.11

307.65

1.5

1.4

ug/g

274.3

274.2

0.00

1995

4045

(3021601) Nitrite [Presence] in Urine by Test strip

31348

153487

1.46

307.65

5.9

4.5

estimate

0.0

0.10

5646

29737

(3034770) Mitochondria Ab [Titer] in Serum

2905

7551

2.40

307.65

1.3

1.2

titre

797.4

970.2

0.72

216

(3020682) Albumin/Creatinine [Ratio] in Urine

19949

89080

1.52

307.65

4.3

4.0

mg/mmol

11.2

8.7

7.29

12684

56631

(3028026) IgM [Mass/volume] in Serum or Plasma

5545

16407

2.15

307.65

1.9

g/l

1.3

0.41

5042

15010

(3000991) Gas panel - Venous blood

6588

23749

1.76

307.65

9.6

8.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8282

31364

1.69

307.65

2.0

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

6477

21927

1.88

307.65

2.4

2.6

g/l

66.3

66.6

2.84

5873

20001

(3018010) Neutrophils/100 leukocytes in Blood

33601

146733

1.79

307.65

6.9

5.7

57.4

57.1

5.30

31344

137835

(3013512) EKG study

20667

81350

1.79

307.65

4.4

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

7465

17343

2.82

307.65

1.3

1.2

—

(3022096) Basophils/100 leukocytes in Blood

32299

139132

1.80

307.65

7.1

5.9

0.7

2.21

30142

130059

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

30059

116715

2.03

307.65

2.2

1.8

pmol/l

95.7

96.3

1.22

16451

61208

(3009261) Glucose [Presence] in Urine by Test strip

31770

154947

1.47

307.65

4.4

3.4

estimate

0.0

0.13

5439

28925

(3003396) Base excess in Arterial blood by calculation

8633

31843

1.74

307.65

8.3

7.1

mmol/l

1.0

0.28

6842

24957

(3000850) Epithelial cells [#/volume] in Urine

15037

62240

1.60

307.65

3.0

2.5

e6/l

5.4

5.7

2.45

13260

54208

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5290

16597

2.02

307.65

4.0

3.5

mmol/l

1.5

1.7

2.01

3950

12117

(3023183) Ammonium ion [Moles/volume] in Plasma

2278

5404

2.62

307.65

3.6

2.4

umol/l

35.7

33.1

4.17

1985

4540

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10768

36542

1.94

307.65

6.9

5.8

mmol/l

1.1

1.0

3.25

10101

34052

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12118

50347

1.57

307.65

3.1

2.6

e6/l

1.0

1.2

1.59

7205

28119

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8635

31841

1.74

307.65

8.4

7.1

kpa

5.0

5.1

6.60

8214

30387

(3044640) Blood type and Crossmatch panel - Blood

22894

94458

1.72

307.65

2.9

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

13686

44287

2.11

307.65

2.9

2.4

umol/l

12.7

14.0

2.38

12682

41069

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

17778

71052

1.71

307.65

2.8

2.2

—

(3026008) Bacteria identified in Urine by Culture

20481

86855

1.63

307.65

3.5

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8293

31162

1.70

307.65

2.0

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

58701

321560

1.95

307.65

20.5

12.3

mg/l

21.9

23.6

31.43

49878

250480

(3019309) Folate [Moles/volume] in Red Blood Cells

15240

49865

2.11

307.65

1.9

1.7

nmol/l

1133.1

1180.9

7.64

11836

37780

(3027945) Reticulocytes/100 erythrocytes in Blood

9602

29678

2.13

307.65

2.5

2.6

1.8

1.7

16.38

8375

26399

(3004789) Transferrin [Mass/volume] in Serum or Plasma

12745

40607

2.12

307.65

2.9

2.4

g/l

2.4

2.3

5.20

11798

37525

(3002030) Lymphocytes/100 leukocytes in Blood

34011

149037

1.79

307.65

7.2

5.9

27.7

28.3

19.99

31680

139327

(3026493) Urate [Moles/volume] in Serum or Plasma

18322

79654

1.55

307.65

2.9

2.5

umol/l

3523.7

4263.3

1.78

15810

69763

(3031040) Bacteria [#/volume] in Urine by Automated count

42872

202085

1.82

307.65

5.5

4.0

e6/l

1401.3

1354.0

0.05

491

2978

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

9119

34552

1.70

307.65

4.7

4.2

32.4

32.0

2.58

6487

24096

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

27942

108706

1.97

307.65

4.3

3.2

ng/l

51.1

67.2

0.90

19000

69502

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

20565

76678

1.91

307.65

3.2

2.9

ng/l

1472.4

1349.1

2.52

17377

65089

(3021960) Folate [Moles/volume] in Serum or Plasma

17578

63685

1.92

307.65

1.7

1.5

nmol/l

20.5

20.2

1.06

15205

55040

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

11935

37545

2.14

307.65

3.0

2.5

21.9

23.3

19.75

10137

32183

(40768797) Stomach Pathology biopsy report

21605

27932

6.49

307.65

1.3

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

16046

57725

1.91

307.65

1.6

1.4

g/l

2.5

2.3

15.05

9663

35932

(3016502) Oxygen saturation in Arterial blood

7841

28309

1.77

307.65

8.7

7.5

95.7

0.45

7552

27236

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

53060

287753

1.60

307.65

6.8

5.2

mmol/mol

40.3

39.3

88.41

49224

267882

(3004588) Protein electrophoresis panel - Serum or Plasma

5418

17611

1.95

307.65

2.2

2.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7082

26280

1.71

307.65

9.3

7.9

g/l

120.0

122.5

17.26

6854

25308

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

12908

52950

1.60

307.65

1.3

iu/ml

28.8

36.6

4.22

3936

16638

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

54324

292052

1.72

307.65

5.6

4.5

mu/l

2.0

2.1

1.23

50151

269547

(36304419) Bacteria [Presence] in Urine

18546

80915

1.54

307.65

3.6

2.9

—

(3020779) Urea [Moles/volume] in Serum or Plasma

7237

24565

1.89

307.65

9.4

7.2

mmol/l

9.9

9.5

5.20

6909

23346

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5526

17407

2.01

307.65

4.0

3.6

kpa

5.1

0.49

5131

16073

(3000494) Fungus identified in Specimen by Culture

8889

34356

1.66

307.65

1.6

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

20731

90644

1.57

307.65

3.8

3.1

e6/l

85.9

91.3

0.17

16493

68658

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11335

46998

1.56

307.65

3.3

2.8

e6/l

2.8

2.9

0.28

6455

24948

(3019069) Monocytes/100 leukocytes in Blood

33394

144348

1.82

307.65

7.4

6.1

8.6

8.5

1.99

31297

135589

(3027801) Oxygen [Partial pressure] in Arterial blood

8629

31823

1.74

307.65

8.4

7.1

kpa

12.0

12.7

25.20

8216

30350

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

39646

152053

2.45

307.65

6.9

5.8

umol/l

11.1

11.4

3.26

37673

143748

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7911

26568

1.92

307.65

2.2

nmol/l

363.0

375.9

5.91

7255

24554

(40768804) Tissue Pathology biopsy report

26592

125519

1.48

307.65

2.2

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

31426

134938

1.79

307.65

3.6

2.7

ug/l

122.9

0.00

29142

125795

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6159

20240

1.94

307.65

4.3

3.8

ng/l

95.8

89.1

4.58

5303

17578

(3015377) Calcium [Moles/volume] in Serum or Plasma

23023

99010

1.63

307.65

3.3

3.4

mmol/l

2.3

2.4

15.71

19715

87354

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

10460

32210

2.15

307.65

3.3

2.6

umol/l

8.3

8.5

0.42

9071

27811

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4299

11549

2.35

307.65

1.7

g/l

1.5

1.05

3714

9817

(3006315) Basophils [#/volume] in Blood

35482

153457

1.87

307.65

6.8

5.7

e9/l

0.0

3.92

31402

132676

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

53834

300031

1.48

300.28

17.5

11.6

ml/min/173m2

80.9

83.7

142.46

46005

245831

(3011397) Hemoglobin [Presence] in Urine by Test strip

15568

70646

1.44

291.95

4.2

3.4

—

(3044889) 12 lead EKG panel

40827

217431

1.37

288.84

4.3

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2689

7423

2.25

288.21

1.3

—

(3019060) Gas panel - Arterial blood

5156

18038

1.80

287.36

5.5

4.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

5401

19205

1.77

285.04

1.4

1.3

u/ml

197.3

253.8

3.80

5020

17814

(3003327) Ova and parasites identified in Stool by Light microscopy

3292

9932

2.07

283.11

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

14628

66121

1.44

277.70

4.7

3.7

kg/l

1.0

0.47

2570

9521

(3025941) Bacteria identified in Stool by Culture

4969

17376

1.80

276.89

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2211

5778

2.37

267.87

1.4

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4598

15942

1.81

262.91

1.8

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4726

16574

1.79

260.17

4.1

3.3

g/l

126.3

130.4

25.31

4609

16202

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4721

16605

1.78

257.26

1.6

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1853

4582

2.50

252.14

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4478

15611

1.80

251.06

1.1

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

24003

119668

1.34

246.20

4.6

3.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

3034

9384

2.01

243.27

3.2

3.5

u/ml

948.6

2158.9

0.92

2565

8074

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4802

17335

1.74

238.69

8.2

6.8

mmol/l

24.5

24.6

1.45

4495

16142

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2882

8831

2.03

236.89

2.9

2.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

2116

5758

2.27

233.75

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3763

12733

1.84

231.57

3.4

2.9

1.4

1.3

4.64

3749

12664

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3030

9544

1.97

230.71

2.4

2.3

ug/l

510.2

540.8

0.14

2851

8877

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3952

13607

1.81

230.04

5.0

4.3

mmol/l

24.1

0.21

3561

12241

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3665

12353

1.85

228.23

1.4

1.6

u/ml

8.3

15.6

3.35

365

(3017732) Neutrophils [#/volume] in Blood

5492

20848

1.65

226.45

2.9

2.7

e9/l

4.1

0.24

4078

16565

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3473

11560

1.87

224.73

2.1

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

59530

342675

1.54

224.36

22.8

14.2

umol/l

79.8

76.1

86.40

59507

342493

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

59696

343863

1.55

223.92

13.8

9.3

u/l

26.9

26.6

2.07

58073

332151

(3027273) Bicarbonate [Moles/volume] in Venous blood

3803

13079

1.81

221.94

4.1

3.3

mmol/l

25.1

25.3

1.56

3707

12660

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3089

9933

1.93

221.50

2.1

2.2

g/l

7.4

7.3

0.32

2227

7490

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3080

9904

1.93

220.85

2.1

2.2

g/l

3.8

0.87

2125

7142

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3660

12487

1.83

219.07

3.4

2.9

0.7

1.02

3551

11938

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3079

9928

1.93

218.97

2.1

2.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1384

3236

2.63

210.18

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1385

3240

2.63

210.13

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1418

3370

2.59

208.62

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1380

3237

2.62

208.27

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1391

3288

2.60

206.82

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4187

15120

1.73

206.72

10.8

9.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1389

3283

2.60

206.55

1.5

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

4714

17596

1.68

206.32

10.7

9.1

93.8

94.0

0.66

4694

17531

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2870

9267

1.92

202.95

2.1

2.3

g/l

10.1

10.3

1.06

2359

7777

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2025

5753

2.17

201.64

7.5

5.3

iu/ml

1064.9

1970.7

0.47

390

770

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2562

7974

1.99

201.17

1.3

u/ml

31.1

37.4

0.55

139

491

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2954

9662

1.90

201.02

1.6

titre

233.7

291.1

0.55

115

416

(3021589) Normoblasts [#/volume] in Blood

27100

140094

1.30

200.95

11.6

9.0

e9/l

0.0

0.23

22546

114832

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

3164

10642

1.85

197.58

2.1

2.0

ug/l

2.5

2.2

0.41

2800

9361

(40761535) Cells panel - Urine sediment

5930

23695

1.57

197.01

4.0

3.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2398

7344

2.02

196.76

1.3

u/ml

7.8

8.4

0.18

404

1109

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2873

9388

1.90

195.97

2.1

2.3

g/l

3.0

3.1

0.41

2168

7345

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3143

10582

1.84

195.61

1.9

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4040

14664

1.72

195.49

10.5

9.3

mmol/l

24.2

24.3

0.69

3744

13700

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2783

9018

1.91

194.59

1.9

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1697

4543

2.30

194.24

1.6

g/l

0.7

0.8

1.89

1301

3403

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4652

17613

1.65

192.32

10.6

8.9

1.4

0.67

4608

17503

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4636

17591

1.65

189.93

10.8

9.0

0.7

1.31

4599

17491

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3460

12140

1.77

188.11

4.7

3.8

49.4

48.4

1.45

3423

12008

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2347

7253

2.00

187.75

1.3

u/ml

7.6

6.1

0.33

279

710

(40761511) CBC panel - Blood by Automated count

58557

337779

1.45

187.61

19.2

11.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

14776

70879

1.34

183.18

5.1

4.3

—

(21494755) Public health laboratory ask at order entry panel

3919

37645

0.61

182.35

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2614

8477

1.91

182.14

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1427

3636

2.41

181.98

2.8

2.6

u/ml

273.1

901.7

1.11

1398

3452

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2595

8402

1.91

181.66

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3372

11862

1.77

181.55

1.3

1.2

u/ml

1.2

0.8

0.97

303

1015

(42529406) Shigella sp [Presence] in Stool by Culture

2616

8502

1.90

181.08

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1435

3676

2.40

180.91

1.1

g/l

1.5

3.54

1302

3337

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5261

20869

1.58

179.44

2.4

2.3

au/ml

29.1

22.7

1.95

244

1354

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1985

5859

2.09

179.36

1.3

1.2

u/ml

6.0

5.6

0.07

154

433

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19055

95199

1.30

175.88

4.9

4.6

ug/l

2.9

3.3

0.96

17107

85756

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2564

8392

1.89

173.65

1.1

u/ml

7.8

4.8

1.48

259

1188

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1958

5826

2.07

173.20

1.3

1.2

u/ml

20.0

13.7

0.31

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2736

9161

1.85

172.79

1.8

1.7

g/l

1.2

0.10

2581

8745

(3017143) Hepatitis C virus Ab [Presence] in Serum

8480

37453

1.43

171.79

1.7

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2572

8496

1.87

169.32

2.2

2.4

g/l

0.7

0.9

2.24

2184

7324

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2661

8896

1.85

168.80

1.8

1.7

g/l

0.2

0.29

2500

8464

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3439

12421

1.72

168.61

1.9

2.0

u/l

39.7

39.3

0.50

3064

11114

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2409

7799

1.91

168.48

1.5

iu/ml

15.6

13.6

0.26

193

(3034860) Kappa light chains.free [Mass/volume] in Serum

2481

8144

1.88

166.44

3.0

3.4

mg/l

75.4

56.4

0.39

2046

6521

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2477

8129

1.88

166.29

3.0

3.4

mg/l

44.2

42.2

0.14

2040

6517

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

53174

303240

1.33

163.95

4.4

3.7

mmol/l

1.3

47.66

48854

280729

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4798

19083

1.57

160.98

1.3

au/ml

45.7

49.5

0.41

149

841

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2405

7904

1.88

160.67

2.9

3.3

ratio

6.0

3.8

0.30

171

650

(3020961) Endomysium IgA Ab [Titer] in Serum

3872

14623

1.65

160.57

1.2

1.1

titre

226.2

193.6

0.25

369

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8925

40236

1.40

159.99

2.0

1.7

1.6

1.4

45.02

7699

35863

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8162

36273

1.42

158.63

8.9

6.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

55909

321764

1.35

155.62

5.5

4.5

mmol/l

2.7

2.8

149.88

51708

298850

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4529

17908

1.58

155.60

8.3

7.1

mmol/l

24.8

0.07

4494

17730

(3029937) Albumin [Presence] in Urine by Test strip

16684

83018

1.29

154.17

4.9

3.7

estimate

0.0

0.31

5420

28558

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1495

4203

2.19

152.37

1.3

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3283

12031

1.69

152.32

1.1

u/ml

6.6

7.8

0.09

167

(3004616) Nuclear Ab [Presence] in Serum

1262

3308

2.34

151.23

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3140

11396

1.71

150.88

5.9

4.8

1.7

1.69

2957

10679

(3017181) Myelocytes/100 leukocytes in Blood

6023

25498

1.48

150.77

4.3

4.1

0.9

0.00

1875

6817

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2335

7758

1.86

150.73

2.0

2.2

g/l

37.6

37.9

1.29

1973

6692

(3000492) Spirometry study

6947

30267

1.44

149.83

1.6

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1790

5437

2.03

149.71

1.2

1.3

titre

88.7

136.3

0.65

120

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2278

7558

1.86

147.65

2.0

2.3

g/l

0.0

0.94

2050

6929

(3003181) Sodium [Moles/volume] in Urine

1521

4369

2.14

147.02

1.5

1.4

mmol/l

61.1

63.7

1.44

1177

3459

(3007930) Methemoglobin/Hemoglobin.total in Blood

3070

11203

1.70

144.48

5.9

4.9

0.9

0.64

2900

10489

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2035

6555

1.91

144.18

1.8

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2615

9138

1.77

143.27

3.4

3.2

u/ml

0.3

0.4

6.00

1469

5214

(40760888) Immunoglobulin light chains.free panel - Serum

1915

6076

1.94

141.76

3.0

3.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

54995

316653

1.32

141.21

5.0

4.1

mmol/l

4.6

4.7

146.46

51177

295803

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2114

6955

1.87

140.53

2.0

2.3

g/l

0.0

0.59

1891

6350

(3052851) Hemolysis interference index of Serum or Plasma

2504

8720

1.77

138.72

3.5

3.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2084

6861

1.87

138.22

2.0

2.3

g/l

0.0

0.00

1884

6332

(3047181) Lactate [Moles/volume] in Blood

2518

8800

1.77

137.82

6.6

5.6

mmol/l

1.3

1.70

2229

7787

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

54602

314314

1.31

137.63

4.9

4.1

mmol/l

1.4

1.5

58.83

50485

292477

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1201

3212

2.29

137.55

2.3

1.9

mg/l

23.6

26.5

0.92

315

890

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2131

7081

1.86

137.35

3.2

3.1

mmol/l

24.7

24.6

0.22

1870

6244

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1954

6354

1.89

134.50

1.8

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1706

5300

1.98

134.01

3.0

3.4

u/ml

329.6

910.3

2.16

1537

4817

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

809

1821

2.72

131.92

1.3

1.2

—

(3022621) pH of Urine by Test strip

4659

19239

1.51

130.70

3.3

2.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

803

1810

2.72

130.61

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3890

15473

1.56

129.38

3.0

2.6

e6/l

0.3

0.62

3804

15014

(3027135) IgG subclass 1 [Mass/volume] in Serum

1093

2881

2.33

129.34

1.4

g/l

6.6

6.8

1.09

781

1988

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1482

4439

2.05

128.55

3.4

2.8

u/ml

1282.2

7621.8

1.15

231

(3024139) IgG subclass 3 [Mass/volume] in Serum

1090

2879

2.32

128.39

1.4

g/l

0.4

0.06

782

1992

(3028192) IgG subclass 2 [Mass/volume] in Serum

1090

2880

2.32

128.29

1.4

g/l

3.0

0.10

778

1988

(4062490)

1089

2884

2.31

127.51

1.4

—

(3020891) Body temperature

2967

11091

1.65

127.22

6.0

4.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1386

4079

2.09

125.88

1.5

1.3

—

(3045414) Leukocytes [Presence] in Urine

3390

13148

1.60

125.43

2.0

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

2654

9676

1.69

124.96

4.9

4.0

mmol/l

1.4

2.17

2600

9509

(3021440) Promyelocytes/100 leukocytes in Blood

5622

24373

1.44

122.98

4.4

4.1

0.1

0.03

1702

6342

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1105

2995

2.26

122.73

3.2

3.3

nmol/l

7.1

7.2

0.02

1062

2913

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1554

17190

0.54

120.76

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

850

2062

2.52

119.96

1.1

mg/l

286.2

434.2

0.53

752

1873

(3023419) Bacteria identified in Sputum by Culture

1144

3178

2.21

119.91

2.6

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2543

9326

1.68

117.03

1.6

iu/ml

12.3

5.3

0.52

566

1923

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1322

3930

2.06

116.94

1.3

nmol/l

1.4

1.1

0.13

1264

3794

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1320

3925

2.06

116.69

1.3

nmol/l

0.2

0.03

244

(3002179) Metamyelocytes/100 leukocytes in Blood

5369

23294

1.44

116.63

4.1

3.9

0.7

0.00

1337

4937

(3041096) Erythrocytes [Presence] in Urine by Automated

16665

85209

1.25

116.26

4.0

3.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2229

7917

1.73

115.10

1.9

2.1

mg/l

11.2

10.7

1.73

2068

7426

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1602

5158

1.91

113.44

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1811

6082

1.83

112.68

1.3

1.2

u/ml

39.3

44.4

0.62

187

589

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1758

5849

1.85

112.66

1.7

1.5

—

(3037756) Immunofixation for Serum or Plasma

1649

5378

1.88

112.35

1.7

—

(3024928) Oxygen saturation in Venous blood

1748

5818

1.85

111.87

3.6

3.4

—

(3037121) Protein [Mass/volume] in Urine

2618

9797

1.65

111.51

3.0

3.3

g/l

0.4

0.3

1.75

1098

4499

(3038026) Centromere Ab [Units/volume] in Serum

844

2117

2.44

111.21

1.2

u/ml

44.2

55.8

0.41

(3000330) Specific gravity of Urine by Test strip

3499

14090

1.54

109.64

4.0

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6614

30080

1.37

108.98

3.9

3.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4605

19651

1.45

108.88

3.0

3.4

pmol/l

4.4

4.5

9.51

4035

17635

(3049717) Cytology report of Urine Cyto stain

2734

10424

1.62

108.12

2.5

2.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5491

24240

1.41

107.90

3.0

2.5

ml/min/173m2

65.1

67.7

4.40

2341

9321

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

822

2066

2.43

107.86

1.2

u/ml

73.0

71.2

0.05

(40768443) Skin Pathology biopsy report

3246

12909

1.55

107.49

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

822

2072

2.43

107.20

1.2

u/ml

42.7

48.7

0.29

145

(3028626) Oxygen [Partial pressure] in Capillary blood

1944

6798

1.76

105.84

3.8

3.4

kpa

8.3

8.4

0.91

1807

6335

(3026250) Tacrolimus [Mass/volume] in Blood

578

1221

2.89

105.69

38.3

35.9

ug/l

7.4

7.3

0.48

524

1121

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1195

3573

2.05

104.10

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

556

1159

2.93

104.03

29.1

27.4

ug/l

120.1

119.2

0.10

440

978

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1480

4789

1.90

103.21

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

788

1985

2.43

102.92

1.2

u/ml

8.8

7.6

0.12

128

(3017315) Amylase [Enzymatic activity/volume] in Urine

634

1432

2.71

102.81

1.4

1.2

u/l

269.3

324.3

0.68

581

1351

(3025159) Blasts/100 leukocytes in Blood

5238

23122

1.41

102.69

4.4

4.2

0.2

0.07

1420

5392

(3043409) Potassium [Moles/volume] in Arterial blood

2271

8365

1.67

102.63

5.3

4.3

mmol/l

3.9

0.38

2151

7837

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15644

80380

1.24

101.63

1.7

1.6

mmol/l

1.4

11.97

13304

67861

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1777

6128

1.78

101.37

1.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

714

1728

2.53

101.30

3.1

3.4

nmol/l

117.9

134.9

0.59

698

1701

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1016

2899

2.15

99.78

1.2

u/l

62.9

64.0

0.10

664

1995

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1103

3251

2.08

99.76

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1666

5677

1.80

98.84

1.6

1.3

—

(4035726)

5741

25898

1.38

98.84

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1454

4746

1.88

98.76

1.9

1.6

—

(3044927) Protein electrophoresis panel - Urine

874

2353

2.27

98.62

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14812

75910

1.24

97.82

4.3

4.0

21.9

0.17

6931

35145

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1473

4860

1.86

96.81

1.1

—

(3021901) Oxygen saturation in Capillary blood

1543

5169

1.83

96.69

3.0

2.8

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

850

2282

2.28

96.53

1.2

titre

251.4

137.9

0.70

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

851

2289

2.27

96.23

1.2

titre

161.6

187.0

0.43

150

376

(3010370) Gastrin [Moles/volume] in Serum or Plasma

258

326

4.82

95.27

1.7

pmol/l

71.9

35.9

1.32

220

269

(3004809) Band form neutrophils/100 leukocytes in Blood

1377

4471

1.89

95.03

3.4

3.2

1.4

0.01

1055

3478

(1616796) Gas panel - Central venous blood

1842

6556

1.73

94.25

3.9

3.5

—

(44806118)

1027

3028

2.08

92.82

1.9

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2382

9110

1.61

92.81

2.8

2.7

g/l

3.5

3.6

1.16

2257

8701

(44790049)

1027

3029

2.08

92.74

1.9

1.5

—

(44790047)

1027

3030

2.08

92.66

1.9

1.5

—

(44790048)

1027

3030

2.08

92.66

1.9

1.5

—

(3039000) Anion gap in Blood

1749

6207

1.73

90.39

7.8

6.5

mmol/l

11.3

11.2

0.72

1599

5577

(3018572) Chloride [Moles/volume] in Blood

1749

6208

1.73

90.33

7.8

6.5

mmol/l

104.9

105.2

1.55

1599

5579

(3048929) Epstein Barr virus Ab [Presence] in Serum

2517

9818

1.58

90.32

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1168

3649

1.96

90.21

7.0

6.1

mg/l

11.8

11.3

3.08

1064

3362

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1647

5791

1.75

87.90

1.3

u/ml

300.0

257.8

5.95

1074

3731

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1745

6242

1.72

87.67

1.5

1.4

u/ml

20.0

19.9

0.01

116

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1180

3737

1.93

87.66

1.7

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

867

2454

2.16

86.90

3.8

3.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1808

6573

1.69

85.65

2.3

2.1

g/l

129.1

131.1

2.33

1278

4886

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1254

4089

1.88

85.43

1.5

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1746

6304

1.70

84.82

1.6

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

413

816

3.09

84.58

2.4

1.7

e6/l

540.1

5130.6

2.28

292

539

(3042733) HLA Ab [Presence] in Serum

450

939

2.92

84.16

4.5

5.2

—

(3045424) Erythrocytes [Presence] in Urine

1436

4913

1.79

84.03

1.5

1.4

—

(3010421) pH of Blood

2048

7734

1.63

83.88

4.5

3.7

7.4

1.07

1749

6558

(3042631) Mycobacterium sp identified in Specimen

1135

3602

1.93

83.81

2.7

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2243

8675

1.59

83.34

1.9

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1843

6800

1.66

82.60

1.7

1.6

e6/l

12280.2

13512.3

0.54

1325

4974

(3033799) Differential panel - Peritoneal fluid

369

693

3.25

81.88

2.2

1.7

—

(3002256) Pathology report gross observation

8280

40427

1.28

80.97

1.3

—

(40768441) Liver Pathology biopsy report

732

1990

2.25

80.83

1.7

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

962

2927

2.01

79.99

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

11967

61054

1.23

79.72

1.7

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1702

6214

1.68

79.34

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1702

6217

1.68

79.19

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3704

16073

1.42

79.15

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2094

8069

1.59

78.97

3.8

3.9

mg/l

1.6

1.5

15.40

1924

7451

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

892

2655

2.05

78.69

1.8

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

890

2657

2.05

77.89

3.4

3.2

59.1

58.3

0.42

577

1703

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

688

1853

2.27

77.65

2.1

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

369

719

3.13

77.33

2.4

1.6

e6/l

12601.3

11956.1

0.04

206

373

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5262

24305

1.34

76.89

4.6

3.6

mmol/l

1.2

5.98

4731

21108

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

528

1270

2.54

75.97

1.1

u/ml

9.3

9.4

0.02

217

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

791

2285

2.12

75.40

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

791

2285

2.12

75.40

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

791

2285

2.12

75.40

1.6

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1047

11356

0.55

75.20

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

743

2097

2.16

75.05

1.3

u/ml

0.9

1.4

0.85

356

892

(3027315) Oxygen [Partial pressure] in Blood

1798

6761

1.63

74.84

4.6

3.7

kpa

8.6

8.7

0.74

1761

6590

(3039162) Centromere protein B Ab [Units/volume] in Serum

1113

3651

1.87

74.47

1.3

1.2

u/ml

68.4

45.7

2.02

216

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1590

5811

1.68

73.82

1.6

1.5

u/ml

114.3

110.6

0.51

354

1314

(3013290) Carbon dioxide [Partial pressure] in Blood

1784

6725

1.63

73.52

4.6

3.7

kpa

5.0

0.03

1747

6555

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

813

2398

2.07

73.47

1.1

—

(3008295) Osmolality of Serum or Plasma

864

2609

2.02

73.37

1.5

mosm/kgh2o

277.9

280.4

1.94

670

2036

(3012501) Base excess in Blood by calculation

1783

6724

1.63

73.36

4.6

3.7

mmol/l

2.6

2.5

0.70

1234

4501

(3006922) Hepatitis E virus Ab [Presence] in Serum

723

2039

2.17

73.18

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5211

24206

1.33

73.12

1.4

1.5

—

(3036489) Thrombin time

2791

11648

1.48

73.11

2.2

2.1

21.8

21.4

1.60

2423

10101

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2231

8889

1.54

72.79

1.4

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

820

2440

2.05

72.42

1.7

1.4

promille

1.5

1.4

0.98

646

1863

(3008757) Leukocyte morphology finding [Identifier] in Blood

947

2970

1.95

72.39

3.7

3.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

995

3177

1.92

72.21

1.3

nmol/l

25.9

30.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1081

3556

1.86

71.71

1.5

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

847

9633

0.53

71.56

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

832

2504

2.03

71.30

3.1

2.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1133

3792

1.83

71.21

1.8

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

600

7606

0.47

70.84

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

578

7422

0.47

70.79

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

579

7410

0.47

70.25

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

496

1204

2.51

70.11

2.2

1.9

umol/l

108.2

146.1

1.81

262

594

(3000093) Morphology [Interpretation] in Blood Narrative

847

2595

2.00

69.16

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

791

9078

0.52

68.83

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

792

9082

0.52

68.74

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1391

5001

1.70

68.59

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1587

5914

1.65

68.41

2.7

2.0

nmol/l

0.9

0.8

1.71

1303

4992

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

413

926

2.72

68.09

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2392

9815

1.50

68.03

2.5

2.4

90.5

92.6

3.89

2233

9133

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

793

9058

0.53

67.94

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

789

9025

0.53

67.91

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

611

1659

2.25

67.75

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

452

1066

2.59

67.69

3.2

2.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

663

1866

2.17

67.48

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

477

1162

2.50

66.97

1.9

1.8

umol/l

2.0

0.10

443

1097

(4094501)

1999

7918

1.55

66.91

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1292

4588

1.72

66.59

1.3

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

663

1878

2.16

66.44

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

995

3268

1.86

66.35

2.7

2.3

mmol/l

105.6

105.7

0.29

989

3242

(3026692) Albumin [Mass/volume] in Peritoneal fluid

297

556

3.25

66.35

1.6

1.3

g/l

11.1

14.6

7.15

209

436

(3041354) Potassium [Moles/volume] in Venous blood

995

3270

1.86

66.23

2.7

2.3

mmol/l

4.1

0.32

989

3244

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1939

7649

1.56

66.07

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

599

1632

2.24

65.90

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2206

8961

1.51

65.80

2.6

195.7

183.8

7.04

2071

8517

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2055

8245

1.53

64.91

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

977

3213

1.86

64.90

2.7

2.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

622

1734

2.19

64.81

2.8

2.0

94.8

99.6

2.32

576

1626

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

640

7703

0.50

64.75

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

594

1629

2.23

64.37

1.3

1.2

u/l

93.2

90.5

0.23

520

1435

(1761482) Bacteria [#/volume] in Urine by Culture

1817

7111

1.57

64.09

4.8

3.8

—

(3008037) Lactate [Moles/volume] in Venous blood

1581

5997

1.62

63.53

3.9

3.0

mmol/l

1.6

0.43

1549

5873

(3035637) Corticotropin [Mass/volume] in Plasma

1078

3687

1.79

63.18

1.5

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

578

1582

2.23

62.94

1.3

1.2

u/l

23.0

24.9

0.40

496

1370

(1761868) Lipid panel - Serum or Plasma

17952

122039

0.85

62.92

3.1

2.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

481

1214

2.42

62.78

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

481

1215

2.41

62.67

1.5

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4188

33102

0.75

62.49

1.8

1.7

—

(3044007) Cell count panel - Peritoneal fluid

322

659

2.98

62.39

2.4

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

1633

6278

1.59

62.11

2.8

2.4

16.3

16.6

2.41

895

3185

(21494890) Protein electrophoresis panel - 24 hour Urine

842

2676

1.92

62.00

1.9

2.1

—

(3006270) Folate [Moles/volume] in Blood

753

2302

2.00

61.90

1.2

1.1

nmol/l

348.8

378.3

2.91

630

1945

(3038515) Glucose [Moles/volume] in Venous blood

1496

5636

1.63

61.78

4.0

3.0

mmol/l

7.5

7.6

0.19

1466

5537

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

603

1695

2.17

61.61

1.6

u/l

6.6

6.3

0.11

288

836

(3030905) Polymorphonuclear cells [#/volume] in Blood

1593

6117

1.60

60.88

3.4

3.3

e9/l

4.2

4.1

0.41

1586

6108

(3011412) CD3 cells [#/volume] in Blood

881

2862

1.88

60.79

2.1

2.5

e9/l

1.2

0.29

498

1750

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4694

22041

1.32

60.57

1.2

iu/ml

121.2

145.9

3.96

1650

8454

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

755

8434

0.54

59.99

1.5

—

(3021788) Differential panel - Synovial fluid

1397

5235

1.63

58.93

1.6

1.5

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

603

1735

2.12

58.19

2.8

2.9

ug/l

28.5

26.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1193

4332

1.68

56.76

1.6

—

(3024932) HLA-DR beta [Type]

392

947

2.52

56.08

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

655

1977

2.02

55.81

2.2

2.7

e9/l

0.2

2.35

576

1688

(4146454)

856

2837

1.84

55.57

2.8

2.7

—

(3024471) HLA-A [Type]

396

973

2.48

54.75

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

258

500

3.14

54.72

1.4

1.3

g/l

21.8

42.0

1.09

185

403

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

668

2051

1.99

54.33

2.1

2.7

e6/l

519.4

535.2

0.22

574

1693

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

420

1068

2.40

54.04

1.3

1.2

—

(3008898) HLA-B27 [Presence]

2556

11104

1.41

53.87

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1215

4498

1.65

53.75

1.1

u/ml

3.7

2.9

0.89

427

2359

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1727

6969

1.52

53.08

2.5

2.4

ug/min

129.1

105.9

1.07

1040

4180

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

434

1130

2.34

53.06

2.0

1.8

umol/l

27.6

29.5

3.44

412

1096

(3011985) Renin [Units/volume] in Plasma

1101

3985

1.69

53.03

1.6

1.5

mu/l

67.8

66.4

0.07

980

3576

(4015189)

289

614

2.87

52.63

2.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

349

826

2.57

52.05

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1170

4328

1.65

51.93

1.3

u/l

40.2

31.3

1.37

1017

3777

(3032057) Clostridioides difficile [Presence] in Stool

252

499

3.08

51.67

1.9

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

361

873

2.52

51.59

1.9

1.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

299

658

2.77

51.17

1.3

umol/l

17.1

16.7

0.57

262

596

(3027923) C peptide [Moles/volume] in Serum or Plasma

525

1509

2.12

50.87

1.6

nmol/l

1.2

1.3

0.09

407

1198

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

559

1657

2.06

50.05

1.4

u/l

6.0

5.9

0.09

466

1402

(3028271) Lactate [Moles/volume] in Capillary blood

1230

4654

1.62

49.96

2.1

1.8

mmol/l

1.8

1.7

0.25

1209

4532

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1398

5458

1.57

49.83

3.7

3.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

536

6274

0.51

49.71

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

51352

301047

1.16

49.19

21.2

13.3

39.1

40.1

104.41

35582

226514

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1254

4800

1.60

48.60

3.2

3.0

nmol/l

0.8

0.65

928

3706

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

490

1408

2.12

47.56

1.1

u/l

91.1

83.8

0.77

413

1099

(3019832) Treponema pallidum Ab [Presence] in Serum

4504

34129

0.79

47.50

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

482

1378

2.13

47.38

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

482

1378

2.13

47.38

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

482

1378

2.13

47.38

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

482

1379

2.13

47.30

1.8

1.9

—

(21494434) Karyotype in Bone marrow

685

2227

1.88

47.27

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

557

1685

2.02

47.26

1.3

1.2

mmol/l

32.0

34.9

2.10

472

1454

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

489

1409

2.12

47.14

1.1

u/l

27.0

24.1

0.37

395

1058

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

702

2304

1.86

47.06

1.2

1.1

u/ml

85.3

59.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1840

7710

1.46

47.05

1.3

1.4

mg/l

511.8

537.7

0.63

1726

7384

(4024509)

749

2510

1.82

47.03

1.7

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2759

22265

0.74

47.00

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

848

2958

1.75

46.63

3.7

3.4

—

(3014051) Protein [Presence] in Urine by Test strip

1587

6520

1.49

44.80

2.3

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

521

1570

2.02

44.71

1.4

1.5

ug/l

7.6

7.9

0.19

481

1416

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

888

3179

1.71

44.59

1.9

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

355

915

2.36

44.48

1.9

1.6

u/ml

47798.9

18831.7

0.41

112

(3016244) Insulin [Units/volume] in Serum or Plasma

608

1943

1.91

44.21

3.2

3.3

mu/l

28.5

27.4

0.23

573

1825

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

248

535

2.82

44.08

2.4

2.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1018

3794

1.64

43.96

2.0

1.7

89.9

89.8

0.21

1004

3729

(3040151) Glucose [Moles/volume] in Capillary blood

903

3262

1.69

43.88

13.8

6.6

mmol/l

7.6

7.2

1.19

716

2692

(3007461) Platelets [#/volume] in Blood

60910

363022

1.23

43.23

30.1

18.2

e9/l

252.9

252.8

0.06

59873

353324

(3003434) Protein [Mass/volume] in Pleural fluid

949

3493

1.66

43.01

1.5

1.4

g/l

31.7

33.5

3.74

842

3166

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

678

2266

1.83

42.99

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

868

3129

1.69

42.53

1.5

1.4

e6/l

4063.8

2942.6

0.46

628

2274

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1163

4518

1.57

42.40

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2272

10101

1.38

41.74

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

989

3708

1.63

41.74

1.3

1.4

pmol/l

336.7

294.5

0.67

746

2907

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9718

51291

1.18

41.46

1.7

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

929

3445

1.65

40.94

1.1

iu/ml

1.7

2.1

0.36

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

354

947

2.28

40.88

2.4

2.0

ug/l

58.0

60.7

0.23

347

924

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1621

6818

1.46

40.67

1.2

1.3

mmol/l

3.8

3.7

2.32

1498

6428

(3035941) MCH [Entitic mass]

60915

363321

1.23

40.25

29.9

18.1

30.2

30.3

3.37

60260

358260

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

961

3617

1.62

39.96

1.6

1.5

56.1

57.0

0.27

606

2308

(4211845)

472

1433

2.01

39.77

3.7

2.6

—

(3024731) MCV [Entitic volume]

60916

363372

1.22

39.76

30.0

18.1

91.0

90.8

25.98

60263

358293

(3006462) Nitrate [Presence] in Urine

439

1299

2.06

39.62

3.8

2.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10353

55109

1.17

39.50

3.0

2.9

ug/l

0.7

0.8

4.02

7054

34830

(3026361) Erythrocytes [#/volume] in Blood

60917

363406

1.22

39.46

30.1

18.1

e12/l

4.4

4.5

289.53

59693

352746

(3047007) Chlamydophila sp Ab [Presence] in Serum

1151

4542

1.55

39.23

1.3

1.2

—

(3010813) Leukocytes [#/volume] in Blood

60923

363486

1.22

39.02

30.1

18.2

e9/l

6.9

6.7

39.58

59722

352802

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

183

355

3.14

38.93

2.7

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

471

1442

1.99

38.80

1.6

1.5

umol/l

21.7

26.3

2.64

442

1377

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

237

536

2.69

38.73

1.3

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

749

2661

1.72

38.73

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

745

2645

1.72

38.61

1.4

e6/l

142628.3

93649.5

0.97

489

1850

(3044941) Cell count panel - Synovial fluid

1131

4464

1.55

38.52

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

60921

363524

1.22

38.46

30.3

18.2

g/l

133.3

136.3

307.65

60272

358482

(3028308) Erythrocytes [#/volume] in Pleural fluid

785

2831

1.69

38.45

1.5

1.4

e6/l

62421.1

50177.7

0.60

463

1705

(3022493) Free Hemoglobin [Mass/volume] in Plasma

409

1192

2.09

38.42

3.8

5.6

mg/l

1011.5

3001.3

1.42

289

867

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

322

4091

0.48

38.39

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4849

24153

1.24

38.04

2.4

2.2

nmol/l

12.7

12.4

1.29

4242

21579

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

661

2280

1.77

37.87

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

660

2278

1.77

37.73

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

661

2283

1.77

37.71

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

666

2306

1.76

37.67

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

665

2303

1.76

37.59

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

665

2304

1.76

37.54

1.2

—

(3010503) CD19 cells [#/volume] in Blood

537

1741

1.88

37.50

2.3

2.7

e9/l

0.2

0.3

0.99

524

1694

(1175426) CD3 cells/100 lymphocytes in Blood

668

2323

1.75

37.24

1.9

2.2

73.0

72.6

0.25

644

2232

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

374

1066

2.14

37.19

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

374

1067

2.14

37.10

1.9

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

659

2286

1.76

37.05

1.8

2.2

13.6

14.0

0.31

328

1082

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

880

3304

1.63

36.99

1.2

—

(3017704) Immunofixation for Urine

450

1384

1.98

36.64

1.6

—

(3012441) Differential panel - Pleural fluid

746

2690

1.69

36.59

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

377

1086

2.11

36.52

1.9

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

1512

6416

1.44

36.24

1.3

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

340

950

2.18

35.53

6.3

6.2

mmol/l

24.7

25.2

1.60

305

870

(3020876) Protein [Mass/time] in 24 hour Urine

662

2331

1.73

35.38

2.0

g/24h

1.1

1.0

0.11

138

(3020491) Glucose [Moles/volume] in Blood

629

2185

1.76

35.23

1.8

mmol/l

6.9

6.7

0.56

456

1608

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

918

3533

1.59

34.91

2.4

2.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

630

2199

1.75

34.72

2.3

2.7

e6/l

702.9

734.7

0.20

299

820

(40768806) Pleura Pathology biopsy report

738

2695

1.67

34.57

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

386

1147

2.05

34.54

2.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

565

1912

1.80

34.54

1.5

1.4

u/l

13.2

12.4

1.65

542

1852

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

499

1628

1.87

34.25

1.3

titre

739.7

371.3

0.69

118

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

560

1903

1.79

33.79

1.5

u/ml

23.4

25.1

0.36

395

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

580

1992

1.78

33.78

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

253

635

2.43

33.72

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

5294

26943

1.21

33.47

4.9

3.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

656

2345

1.71

33.26

1.3

mmol/l

2.0

2.1

0.89

602

2179

(3014271) Vancomycin [Susceptibility]

418

1299

1.96

33.12

3.2

2.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

599

2090

1.75

33.08

1.7

1.4

umol/l

68.7

70.1

0.20

172

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

484

1584

1.86

32.93

1.3

titre

47.4

84.2

1.53

137

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

427

1340

1.94

32.91

1.6

nmol/l

3.2

9.3

0.79

350

1124

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

913

3560

1.57

32.87

2.1

2.2

32.2

32.8

2.71

904

3534

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

614

2162

1.73

32.86

1.9

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

867

3343

1.58

32.74

1.9

ug/l

24.5

25.0

0.05

842

3284

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

655

2357

1.69

32.44

1.4

1.3

u/l

549.0

479.6

0.27

613

2242

(3005570) Glucose [Moles/volume] in Urine

768

2883

1.63

32.37

2.0

1.8

mmol/l

2.6

25.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

428

1357

1.92

32.04

1.6

mmol/24h

5.5

0.03

104

(44813793)

615

2184

1.72

31.95

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

307

860

2.17

31.95

2.5

3.3

—

(40768446) Kidney Pathology biopsy report

387

1187

1.99

31.84

1.9

1.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

705

2601

1.65

31.81

1.4

1.3

nmol/l

1.5

1.4

0.55

636

2357

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1563

6842

1.40

31.53

1.2

—

(3003129) Base excess in Capillary blood by calculation

249

645

2.35

31.06

1.6

1.7

mmol/l

0.4

0.5

0.16

232

607

(3045683) HLA typing for celiac disease panel - Blood or Tissue

539

1858

1.77

31.06

1.0

—

(3048879) Bone marrow aspiration report

263

700

2.29

30.89

1.7

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

335

986

2.07

30.81

1.3

1.2

111.5

111.1

0.10

299

880

(3023420) DNA double strand Ab [Units/volume] in Serum

852

3322

1.56

30.72

1.6

1.5

iu/ml

36.6

31.9

0.32

143

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1155

4812

1.47

30.52

1.3

1.2

u/ml

3.8

3.9

0.03

543

2112

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1710

7646

1.37

30.35

1.8

1.9

iu/l

19.4

12.3

0.33

593

2871

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

243

630

2.35

30.28

1.2

pmol/l

367.7

302.6

0.44

174

473

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

425

1374

1.88

30.07

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1559

6880

1.39

29.99

1.3

1.5

e6/l

28.8

32.1

0.13

1208

5319

(3045142) Bone marrow Pathology biopsy report

780

2996

1.59

29.99

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1560

6886

1.38

29.97

1.4

1.5

e6/l

2109.3

2116.2

0.00

1282

5589

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

268

729

2.24

29.96

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

406

1298

1.91

29.71

1.5

1.6

—

(3051651) Icteric interference index of Serum or Plasma

505

1731

1.78

29.69

4.1

3.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

406

1299

1.90

29.64

1.5

1.6

—

(3019977) pH of Arterial blood

459

1530

1.83

29.55

2.6

2.5

7.4

0.16

163

525

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

351

1069

2.00

29.49

1.3

1.2

g/l

0.3

0.32

285

839

(3036782) Glucose [Moles/volume] in Pleural fluid

670

2492

1.64

29.35

1.4

1.3

mmol/l

6.3

0.07

617

2310

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

343

1040

2.01

29.18

2.2

2.0

mg/l

8.7

9.4

1.45

291

820

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

477

1616

1.80

29.16

2.3

2.6

u/ml

1143.5

1031.8

0.29

469

1599

(40757373) Influenza virus identified in Isolate

207

507

2.48

29.12

2.0

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

293

848

2.10

28.20

2.0

1.4

—

(3045788) Cell count panel - Pleural fluid

652

2435

1.63

28.13

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1082

4524

1.46

28.11

2.1

2.2

titre

11.3

6.4

0.51

141

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1163

4938

1.44

27.88

1.1

au/ml

12.7

11.1

0.27

329

(21494815) CD4 cells/100 lymphocytes in Specimen

703

2683

1.60

27.80

2.0

2.3

41.5

40.8

0.16

333

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

526

1864

1.72

27.63

1.3

u/l

13.2

14.4

0.39

474

1732

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1836

8430

1.33

27.43

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

442

1492

1.80

27.38

2.2

umol/l

26.5

31.8

0.30

132

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

222

586

2.31

26.66

1.6

1.5

ug/l

0.4

0.21

153

382

(3004451) EKG impression Narrative

391

1283

1.86

26.52

1.3

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

108

192

3.42

26.41

3.0

1.8

58.9

59.5

0.05

123

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1633

7427

1.34

26.03

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

604

2260

1.63

25.92

2.4

2.2

714.8

664.3

2.04

454

1506

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

455

1577

1.76

25.86

1.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

161

370

2.65

25.74

1.4

1.5

nmol/l

50421.7

287704.2

1.55

121

317

(3033923) Metanephrine [Moles/time] in 24 hour Urine

210

551

2.32

25.58

1.1

umol/24h

0.8

3.3

0.49

277

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

360

1168

1.88

25.30

3.0

3.2

mg/l

8.0

7.9

0.16

288

928

(37021550) Renin [Units/volume] in Plasma --upright

212

564

2.29

25.05

1.3

mu/l

81.3

76.3

0.09

157

428

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

268

786

2.08

25.01

1.7

1.6

ug/l

9.6

8.9

1.77

268

786

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

461

1623

1.73

24.84

1.8

u/field

2.2

2.4

0.20

345

1161

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

666

2581

1.57

24.77

2.1

2.2

nmol/l

18.9

18.6

0.32

625

2448

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

533

1957

1.66

24.64

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

252

728

2.11

24.46

1.3

nmol/l

143.3

120.0

1.14

191

536

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

726

2882

1.54

24.30

1.4

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

148

3.66

23.95

3.2

1.6

11.6

16.6

0.78

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

532

1968

1.65

23.92

1.1

iu/ml

7.6

8.5

0.34

124

518

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

406

1396

1.77

23.76

1.5

1.6

iu/ml

2918217.0

1785677.5

0.55

100

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

474

1704

1.69

23.74

1.1

nmol/l

4.4

4.9

0.10

344

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1147

5005

1.40

23.68

1.3

1.2

u/ml

3.2

3.8

0.59

410

1699

(3016750) Collection duration of Urine

466

1672

1.70

23.51

2.3

2.1

min

501.1

499.0

0.19

381

1204

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

789

3212

1.50

23.51

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3238

16252

1.22

23.37

2.8

3.3

u/ml

46.9

51.7

0.46

3103

15731

(4306422)

1113

4848

1.40

23.23

1.2

—

(4268621)

794

3249

1.49

23.09

2.2

2.3

—

(3028433) Virus identified in Specimen by Culture

300

946

1.93

23.01

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

203

553

2.23

22.77

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

329

1074

1.86

22.76

2.6

2.7

au/ml

151.1

153.4

0.03

144

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

792

3249

1.49

22.75

1.1

au/ml

51.2

68.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1136

4984

1.39

22.74

1.1

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

274

841

1.98

22.69

1.8

1.7

au/ml

105.0

136.9

0.40

112

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

350

1167

1.83

22.67

1.9

2.2

29.0

28.9

0.02

333

1105

(3047189) Immunofixation for 24 hour Urine

352

1181

1.81

22.36

1.6

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

484

4687

0.62

22.36

1.4

1.3

ug/l

4.3

3.5

0.43

416

4151

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

901

3808

1.44

22.25

1.7

1.9

titre

5470.6

3632.6

0.26

172

(3006245) CD3-CD19+ cells/100 cells in Blood

355

1198

1.80

22.14

1.9

2.3

10.8

10.6

0.06

328

1118

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

348

1168

1.81

22.09

1.1

—

(3036603) Volume of Urine

524

1973

1.62

22.03

1.7

1.6

1820.6

1995.8

1.60

148

418

(40762365) Oxygen content in Arterial blood by calculation

167

424

2.40

21.95

2.8

3.1

ml/dl

15.0

14.8

0.29

158

390

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1182

5254

1.37

21.88

1.4

1.3

u/l

26.7

26.4

0.12

932

4371

(3008116) Ketones [Moles/volume] in Urine by Test strip

202

560

2.19

21.77

1.7

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

358

1227

1.78

21.25

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

249

761

1.99

20.92

1.9

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

365

1269

1.75

20.66

4.0

3.7

—

(3051593) INR in Capillary blood by Coagulation assay

355

1225

1.76

20.61

8.5

10.6

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

559

2177

1.56

20.47

1.4

umol/l

12.6

11.9

1.61

525

2075

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

383

1356

1.72

20.36

2.1

2.3

ug/l

79.0

209.0

0.71

367

1295

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

168

447

2.29

19.97

1.3

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

790

3328

1.45

19.91

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

205

597

2.09

19.62

1.0

1.1

u/ml

1.7

2.5

—

(3052592) Norovirus Ag [Presence] in Stool

189

533

2.16

19.60

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1085

4845

1.37

19.58

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

210

619

2.06

19.48

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

558

2198

1.55

19.47

1.8

1.9

mg/l

4.1

3.6

1.78

529

2091

(3009466) Valproate [Moles/volume] in Serum or Plasma

1038

4612

1.37

19.33

4.9

5.2

umol/l

348.0

371.3

5.65

910

3998

(3012565) Volume of 24 hour Urine

408

1492

1.66

19.30

2.3

2.1

1937.5

2002.9

0.50

377

1325

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

592

2368

1.52

19.27

2.0

u/field

1.8

2.3

1.63

308

1008

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

321

1098

1.78

19.24

2.7

2.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1095

4912

1.36

19.21

1.1

iu/ml

201.2

2884.9

0.72

231

1101

(4034850)

2044

9989

1.25

18.94

11.8

8.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

563

2240

1.53

18.80

1.6

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

199

584

2.07

18.70

1.4

25.7

22.4

0.80

164

485

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1454

6825

1.30

18.68

1.9

pmol/l

196.3

197.4

0.14

1376

6488

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

224

688

1.98

18.63

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1051

4711

1.36

18.55

1.1

119.5

118.0

0.77

957

4266

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

173

482

2.18

18.52

2.2

2.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

705

2951

1.46

18.42

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6720

36458

1.13

18.32

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

899

3938

1.39

18.27

1.7

1.6

—

(3035880) pH of Pleural fluid

387

1424

1.65

17.93

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

399

1482

1.64

17.83

1.2

u/ml

17.3

11.9

0.22

140

(3008536) Aspergillus sp Ab [Presence] in Serum

183

530

2.10

17.82

2.0

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1406

6620

1.30

17.68

1.1

u/ml

1.6

0.00

592

2687

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

455

1750

1.58

17.66

1.6

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

217

675

1.96

17.46

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

217

675

1.96

17.46

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

217

675

1.96

17.46

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

217

675

1.96

17.46

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

101

224

2.74

17.43

3.0

3.8

mg/l

2.2

0.11

189

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

161

3.10

17.41

1.4

1.3

pmol/l

17.3

17.0

0.04

143

(3035320) C reactive protein [Mass/volume] in Body fluid

544

2186

1.52

17.40

2.7

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

435

1663

1.59

17.33

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

244

793

1.87

17.27

1.2

g/l

39.6

40.2

0.25

119

442

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

302

1049

1.75

17.26

1.5

1.4

pmol/l

14.9

14.8

0.02

253

879

(3029075) Extractable nuclear Ab panel - Serum

262

875

1.82

17.05

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

450

1742

1.57

17.02

2.5

2.8

40.5

39.3

0.51

187

551

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

377

1401

1.64

16.85

1.3

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

392

1473

1.62

16.77

1.8

1.9

144.8

142.2

0.24

363

1391

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

179

527

2.07

16.75

5.7

5.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11114

62300

1.10

16.62

1.9

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

206

2.77

16.60

1.8

1.7

umol/l

46.5

45.1

0.15

206

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

104

241

2.62

16.57

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

116

286

2.47

16.36

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

300

1057

1.73

16.35

1.6

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

262

887

1.80

16.34

1.1

u/ml

3.3

7.2

0.46

137

512

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

220

2392

0.56

16.27

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

493

1973

1.52

16.12

1.1

ratio

1.1

0.02

170

697

(3016018) Differential panel - Cerebral spinal fluid

779

3406

1.39

16.08

1.4

1.5

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

150

419

2.18

16.04

1.1

1.0

ug/l

88.1

79.6

1.24

113

355

(3035947) Staphylolysin Ab [Units/volume] in Serum

391

1487

1.60

15.97

1.2

1.1

iu/ml

3.5

4.3

0.72

109

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

214

685

1.90

15.91

9.2

8.3

—

(3016228) CD19 cells/100 cells in Blood

324

1187

1.66

15.36

1.8

2.1

8.3

8.5

0.08

317

1157

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

475

1908

1.52

15.30

1.5

1.4

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

145

3.06

15.28

1.4

2.0

ug/g

181.4

177.7

0.06

126

(21494814) CD8 cells/100 lymphocytes in Specimen

318

1161

1.67

15.27

1.8

2.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

296

1060

1.70

15.27

1.2

1.1

109.3

107.9

0.23

257

972

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

37069

218338

1.07

15.20

3.3

3.1

—

(3000034) Microalbumin [Mass/volume] in Urine

628

2675

1.43

15.07

3.0

2.9

mg/l

48.6

55.8

0.33

460

1899

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

971

4445

1.33

15.03

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

360

1363

1.61

15.01

3.6

3.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

614

2610

1.43

14.90

1.1

1.2

mg/l

37.2

43.9

2.46

517

2177

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

155

453

2.08

14.85

1.1

pmol/l

3.3

7.3

0.55

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

594

2516

1.44

14.71

1.1

mg/l

261.4

267.9

0.21

519

2212

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

183

571

1.95

14.70

1.2

mg/l

37.1

47.1

0.12

129

418

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

284

1017

1.70

14.67

1.1

93.6

90.8

0.55

139

481

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

576

2429

1.44

14.60

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

146

420

2.11

14.57

2.5

2.9

u/l

3150.4

1307.4

0.83

129

379

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

530

2206

1.46

14.39

2.1

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

656

2842

1.41

14.35

1.6

1.5

30.4

31.3

0.23

406

1785

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

719

3170

1.38

14.20

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

778

3479

1.36

14.08

1.2

1.1

94.5

96.2

1.05

728

3266

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

656

2854

1.40

14.02

3.9

4.9

u/ml

121.8

107.5

0.17

182

903

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

293

1072

1.66

14.01

1.9

2.0

166.0

164.2

0.10

272

1019

(3002385) Erythrocyte distribution width [Ratio]

45902

272687

1.07

13.98

24.2

15.0

13.9

13.6

181.62

45192

266804

(40761539) Cells [Type] in Urine sediment by Light microscopy

216

726

1.81

13.89

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

287

1048

1.67

13.83

1.1

91.3

90.2

0.22

138

494

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

130

365

2.17

13.81

2.8

2.5

pmol/l

94.3

63.6

0.80

113

313

(3003721) Smooth muscle Ab [Units/volume] in Serum

182

2.71

13.76

1.1

u/ml

2.6

2.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

226

773

1.78

13.73

1.6

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

411

1640

1.53

13.72

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

207

2.58

13.71

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

255

904

1.72

13.70

1.9

2.3

e6/l

589.6

581.2

0.01

145

493

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

207

690

1.82

13.68

1.3

ug/l

108.2

319.8

1.78

109

371

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

352

1359

1.58

13.59

2.1

ug/min

93.2

105.4

0.17

293

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

258

922

1.70

13.48

1.5

1.4

61.3

62.2

0.14

196

770

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

653

0.25

13.39

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

394

1570

1.53

13.26

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

391

1557

1.53

13.20

1.7

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1936

9781

1.21

13.17

1.8

1.7

nmol/l

41.7

40.7

1.01

1875

9568

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

124

349

2.16

13.12

2.5

u/field

0.6

0.04

124

349

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

172

548

1.91

13.07

2.6

2.5

mmol/l

7.3

7.5

0.24

108

322

(3014148) Varicella zoster virus Ab [Titer] in Serum

913

4234

1.31

12.98

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

160

499

1.95

12.94

2.4

2.6

mg/l

48.7

48.5

0.00

(3017569) Oxygen content in Arterial blood

330

1271

1.58

12.91

2.4

2.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

247

2.39

12.90

1.8

2.1

umol/l

1.3

0.45

220

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

241

858

1.71

12.80

2.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

241

858

1.71

12.80

2.6

2.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1241

6004

1.26

12.70

1.1

u/ml

4.1

5.2

1.78

627

3107

(3039744) RNA polymerase III Ab [Units/volume] in Serum

238

2.40

12.66

1.1

1.0

u/ml

5.1

4.2

0.13

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

316

1212

1.59

12.59

1.1

ng/l

327.8

612.8

0.69

280

(3024263) Appearance of Synovial fluid

380

1525

1.52

12.41

2.0

1.7

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

254

928

1.66

12.29

1.1

1.0

u/ml

10.0

10.2

0.03

111

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

288

1088

1.61

12.23

2.3

2.5

ug/l

1.5

1.0

1.63

269

1026

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

316

1221

1.57

12.23

1.1

—

(1002224) Polysomnography panel

2679

14016

1.17

12.22

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1184

5724

1.26

12.21

1.1

u/ml

0.9

1.1

0.55

507

2423

(4198724)

375

1512

1.51

12.01

2.6

2.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

272

1019

1.62

11.96

1.2

g/l

1.1

0.4

0.72

(3038071) Oxygen [Partial pressure] in Mixed venous blood

181

607

1.81

11.81

9.6

8.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

131

394

2.02

11.76

2.5

3.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

156

2.69

11.66

1.1

u/l

54.3

92.9

0.46

129

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

246

907

1.65

11.53

1.1

—

(44806420)

203

710

1.74

11.53

2.2

2.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.72

11.50

1.4

1.7

nmol/l

205.3

270.4

0.38

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.84

11.44

1.0

1.1

titre

1521.6

2533.5

1.04

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

108

305

2.15

11.40

1.3

u/l

704.9

82.3

0.79

223

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

151

2.70

11.40

1.0

u/ml

0.2

0.6

0.91

138

(3028707) Methadone [Presence] in Urine by Screen method

1188

5794

1.25

11.39

3.1

3.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.53

11.25

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

217

780

1.69

11.21

1.4

1.3

mmol/l

3.3

3.6

0.46

195

720

(3009015) Lactate [Moles/volume] in Synovial fluid

260

2.24

11.20

1.3

1.2

mmol/l

5.7

6.3

0.41

138

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1251

6150

1.24

11.18

1.7

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

146

467

1.90

11.06

1.2

mmol/l

1.6

1.7

0.75

286

(3034988) Calcium [Moles/volume] in Capillary blood

157

517

1.85

10.90

2.2

2.5

mmol/l

1.2

0.87

150

496

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

193

678

1.73

10.84

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

216

783

1.68

10.83

1.5

1.4

3.6

2.7

0.61

165

672

(3013727) Leukocytes other/100 leukocytes in Blood

250

942

1.61

10.80

3.6

3.5

52.6

52.7

0.03

242

909

(40762887) Creatinine [Moles/volume] in Blood

4.56

10.76

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

373

1539

1.47

10.75

1.2

1.3

55.3

62.9

0.52

192

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

209

754

1.69

10.68

2.0

u/l

27.1

41.1

0.88

193

676

(3030313) Adrenal Ab [Titer] in Serum

278

2.16

10.64

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

182

1849

0.60

10.62

1.3

1.4

nmol/l

29.8

31.2

0.26

160

1680

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

148

483

1.86

10.58

2.1

2.3

mmol/l

1.2

0.27

142

462

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.35

10.46

1.1

g/l

0.2

0.56

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

270

1045

1.57

10.46

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

106

309

2.09

10.39

3.0

2.4

mmol/l

0.9

1.4

1.78

223

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.87

10.35

1.5

1.7

nmol/l

259.0

312.8

0.19

(3023410) Appearance of Cerebral spinal fluid

691

3195

1.32

10.17

1.5

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

248

2.21

10.14

1.4

1.1

mg/l

44.0

48.9

0.53

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

172

2.47

10.13

1.1

u/ml

18.9

40.7

1.69

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

172

2.47

10.13

1.1

u/ml

32.8

20.9

0.85

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

135

434

1.89

10.12

5.2

5.1

ug/min

50.8

43.2

0.66

108

338

(3033942) Copper [Moles/time] in 24 hour Urine

119

2.81

10.12

1.1

1.3

umol/24h

1.4

0.6

0.50

(3034426) Prothrombin time (PT)

273

1070

1.55

10.04

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

100

289

2.10

10.04

3.1

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

326

1329

1.49

10.01

2.4

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1919

9948

1.18

9.88

1.4

u/l

10.5

9.9

1.34

1555

8127

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

232

2.23

9.81

1.3

ml/s/173m2

1.3

1.5

0.32

150

(3000012) Reticulocyte production index

374

1574

1.45

9.79

1.3

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

437

1.86

9.65

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

278

1105

1.53

9.63

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

413

1776

1.41

9.63

1.1

u/l

1.1

0.16

188

806

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

151

513

1.79

9.56

1.1

u/ml

2.3

6.7

0.96

111

364

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

109

332

2.00

9.56

1.9

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

129

417

1.88

9.54

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

118

371

1.93

9.47

1.7

1.6

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

152

519

1.78

9.47

3.1

5.3

u/l

66.8

54.6

0.20

209

(3000919) Neutrophils/100 leukocytes in Pleural fluid

194

710

1.66

9.46

1.5

1.3

22.6

21.7

0.17

162

654

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

292

2.06

9.46

2.0

2.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

145

2.56

9.46

1.4

1.2

u/l

1299.2

958.1

0.13

131

(3001686) Cold agglutinin [Titer] in Serum or Plasma

146

493

1.80

9.44

1.4

1.3

titre

34.7

181.3

1.78

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

344

1436

1.46

9.42

1.1

99.6

97.4

0.59

283

1139

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

129

419

1.87

9.41

1.1

u/ml

0.3

0.10

259

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

120

381

1.91

9.37

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

164

2.45

9.37

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

254

2.13

9.26

1.7

1.6

mg/l

2.0

1.6

0.28

168

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

276

2.07

9.11

1.1

umol/24h

1.7

3.1

0.50

276

(3001019) Free T4 and TSH panel - Serum or Plasma

2739

18804

0.88

9.05

1.7

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

269

2.08

9.01

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

294

2.03

8.98

1.0

u/ml

0.1

0.2

1.19

173

(40761995) Spermatozoa Progressive [#/volume] in Semen

801

0.45

8.92

3.3

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

800

0.45

8.90

6.6

6.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

287

2.03

8.89

1.0

1.1

u/ml

0.2

5.7

2.28

220

(40762814) Titanium [Mass/volume] in Blood

130

432

1.83

8.87

2.3

ug/l

3.9

3.7

0.12

144

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

198

742

1.62

8.85

1.4

1.3

35.9

39.6

0.61

128

507

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.16

8.75

3.5

3.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

216

2.19

8.75

1.4

—

13.3

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

2.7

1.9

0.56

158

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

1.8

2.2

0.32

181

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

2.4

0.02

172

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

3.9

3.8

0.04

157

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

1.8

0.03

176

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

3.0

2.3

0.49

167

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

1.9

0.05

151

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

1.1

0.8

0.26

165

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

248

2.11

8.74

1.7

1.6

mg/l

1.0

1.1

0.10

156

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

121

395

1.86

8.74

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

407

1778

1.39

8.72

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

411

1800

1.39

8.68

1.0

ng/l

308.4

335.7

0.56

306

1272

(3024869) Neuronal Ab [Presence] in Serum

145

502

1.76

8.67

1.1

—

(3014891) Appearance of Pleural fluid

112

358

1.90

8.62

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

210

2.20

8.58

1.3

1.2

ug/l

120.4

96.8

0.71

132

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

412

1813

1.38

8.47

1.0

ng/l

777.6

743.8

0.70

297

1233

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

280

2.02

8.47

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3416

23050

0.89

8.45

2.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

200

2.22

8.42

2.2

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

259

1046

1.51

8.41

1.1

—

(4212803)

212

2.18

8.40

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

412

1816

1.38

8.39

1.0

ng/l

39.9

42.1

0.47

303

1258

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

238

946

1.53

8.32

1.9

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

375

1630

1.40

8.30

1.6

—

(4027681)

454

2037

1.36

8.29

1.2

1.3

—

(3025577) Chromium [Mass/volume] in Blood

369

1600

1.40

8.29

2.1

ug/l

2.3

0.08

306

1349

(3020393) Adenovirus Ag [Presence] in Stool

108

347

1.89

8.21

1.3

—

(3018133) Calcium [Moles/volume] in Urine

138

481

1.74

8.10

1.9

2.1

mmol/l

3.0

2.6

1.24

124

434

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1119

5633

1.21

8.10

1.1

u/ml

1.7

2.3

1.19

282

1403

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.90

8.03

1.2

ng/l

2132.8

3512.2

0.67

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.08

8.01

1.1

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

132

2.49

7.99

1.1

—

(44806071)

119

400

1.81

7.89

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

457

2071

1.34

7.85

1.1

u/ml

1.0

2.9

1.17

173

579

(3042010) Triglyceride [Moles/volume] in Pleural fluid

113

375

1.83

7.81

1.2

1.3

mmol/l

1.1

1.4

0.25

242

(43055442) Apixaban [Mass/volume] in Serum or Plasma

101

324

1.89

7.74

1.8

1.5

ug/l

125.2

109.2

0.76

260

(3042951) Complement C1q Ab [Units/volume] in Serum

128

2.47

7.61

1.1

1.3

u/ml

8.4

24.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

250

2.02

7.60

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

110

2.60

7.59

1.3

1.1

g/l

0.1

2.43

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

288

1.94

7.58

1.0

u/ml

5.2

1.8

0.28

154

(3007916) DNA double strand Ab [Titer] in Serum

112

375

1.82

7.54

1.3

titre

112.0

152.7

—

(3019174) dRVVT (LA screen)

268

1.97

7.50

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

176

670

1.60

7.47

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

297

1264

1.43

7.46

1.8

1.9

—

(4281824)

664

3190

1.27

7.44

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

373

1653

1.37

7.42

2.0

ug/l

3.1

3.8

1.39

330

1454

(3049242) von Willebrand panel - Platelet poor plasma

2.85

7.28

1.8

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

162

2.25

7.22

5.5

4.9

—

(3011544) Albumin [Mass/volume] in Pleural fluid

236

2.01

7.09

1.1

g/l

16.1

17.6

0.78

217

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

230

2.01

6.92

1.3

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

115

400

1.75

6.88

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

110

378

1.77

6.86

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

138

506

1.66

6.84

1.3

1.4

ng/l

629.1

111.3

0.45

317

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

282

1.90

6.83

1.0

u/ml

0.1

0.7

1.11

151

(3023436) Glucagon [Mass/volume] in Serum or Plasma

143

2.29

6.81

1.6

1.7

ng/l

215.3

200.1

0.23

128

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

143

2.29

6.81

10.7

9.9

e6/l

145.8

348.8

0.89

105

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

207

2.05

6.78

1.2

29.8

21.6

0.45

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

111

384

1.76

6.77

1.5

1.4

8.7

12.9

1.08

203

(3034891) Synovial lining cells/100 cells in Synovial fluid

334

1478

1.37

6.76

1.6

1.5

4.5

4.3

0.07

341

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

120

425

1.72

6.75

1.9

1.5

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

229

1.99

6.68

1.2

nmol/l

18.6

15.1

0.98

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

176

2.14

6.66

1.0

u/ml

0.1

1.7

1.23

130

(3023430) Cat dander IgE Ab [Units/volume] in Serum

901

4535

1.21

6.63

1.1

u/ml

4.5

5.0

0.24

371

1886

(3014178) Parietal cell Ab [Units/volume] in Serum

6.58

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

235

1.97

6.55

1.4

1.3

pmol/l

14.1

13.2

0.09

197

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

266

1.90

6.46

1.1

u/l

19.7

20.3

0.11

164

(3045716) Anion gap in Serum or Plasma

303

1332

1.38

6.41

2.9

2.4

mmol/l

9.2

0.07

199

1001

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

194

785

1.50

6.38

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

177

703

1.53

6.34

1.3

109.6

107.4

0.33

166

667

(40765096) Chromosome analysis panel by Banding

195

794

1.49

6.23

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

125

459

1.66

6.21

6.9

7.3

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

302

1.81

6.11

1.4

71.2

72.4

0.12

258

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

151

2.17

6.05

4.1

3.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

136

515

1.61

6.00

1.1

1.3

u/ml

0.3

7.8

1.44

121

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1374

7240

1.16

5.93

1.4

pmol/l

150.9

125.5

0.77

1340

7061

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

194

798

1.48

5.93

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

262

1.86

5.88

1.0

u/ml

0.1

0.6

1.33

144

(3002619) Bacteria identified in Specimen by Culture

157

619

1.54

5.85

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

286

1.81

5.75

1.3

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.05

5.73

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

257

1.84

5.64

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

192

797

1.46

5.63

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

167

674

1.51

5.62

1.1

1.2

74.8

76.8

0.14

185

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

185

763

1.47

5.61

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2726

18196

0.91

5.58

1.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

246

1.85

5.51

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

2.93

5.48

1.1

mu/l

29.8

75.2

0.85

(3023511) Choriogonadotropin [Units/volume] in Urine

1252

6595

1.16

5.47

1.4

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

126

2.22

5.45

1.4

1.6

u/l

0.4

0.1

0.61

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

209

1.92

5.39

1.1

u/l

8.2

10.5

0.60

209

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

222

1.89

5.38

1.1

iu/ml

19.4

16.8

0.10

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

598

2956

1.23

5.36

1.3

mmol/l

11.9

11.8

0.02

216

681

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

293

1.76

5.35

1.0

1.1

u/ml

0.4

2.7

1.95

231

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

193

1.95

5.32

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

321

1471

1.33

5.30

1.1

miu/ml

1528.5

1516.8

0.06

321

1471

(3042517) Benzodiazepines panel - Urine

107

395

1.65

5.28

2.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

250

1103

1.38

5.27

2.9

umol/l

28.8

28.7

0.03

187

840

(3014133) Dog dander IgE Ab [Units/volume] in Serum

937

4844

1.18

5.23

1.1

u/ml

3.9

4.5

0.27

383

1892

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.54

5.21

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

116

439

1.61

5.20

1.1

—

(3051339) Copper [Moles/volume] in Blood

145

2.10

5.19

1.1

1.2

umol/l

16.4

16.9

0.30

125

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

333

1.70

5.15

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

330

2605

0.77

5.14

1.5

1.6

mmol/l

8.2

7.6

3.13

197

1576

(40765089) Chromosome analysis panel - Blood by G-banded

111

1053

0.64

5.11

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

833

4279

1.18

5.03

2.0

2.1

umol/l

10.4

6.6

2.72

617

3099

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.42

5.02

1.2

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

131

2.13

5.00

1.0

u/ml

0.0

0.2

1.47

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

181

1.95

4.97

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

798

1.43

4.97

1.1

—

(3025315) Body weight

247

1.80

4.92

5.3

4.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

165

1.99

4.91

1.1

u/l

1.8

3.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

164

680

1.47

4.90

1.1

1.2

89.2

88.7

0.03

197

(40758047) Lysozyme [Mass/volume] in Pleural fluid

230

1.82

4.88

1.3

1.1

mg/l

8.7

9.7

0.30

211

(44786800) Granulocytes/100 leukocytes in Body fluid

316

1.69

4.85

1.4

1.3

25.4

23.3

0.21

247

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.77

4.84

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

426

2053

1.26

4.84

1.1

u/ml

2.6

5.6

0.67

141

495

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

201

1.87

4.78

5.2

5.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

284

1302

1.33

4.73

2.5

2.4

umol/l

55.7

53.1

0.65

225

1094

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

206

1713

0.73

4.68

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

315

1.68

4.67

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

137

555

1.50

4.62

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

108

415

1.58

4.60

1.2

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

108

415

1.58

4.60

1.3

1.4

52.2

52.3

0.00

197

(3012989) Citrate [Moles/time] in 24 hour Urine

2.80

4.57

1.5

1.3

mmol/24h

1.8

2.2

0.72

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

425

2063

1.25

4.57

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

108

2.19

4.56

1.6

3.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

323

1.66

4.50

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

686

4934

0.84

4.50

3.3

2.4

13.3

13.1

2.51

679

4866

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

125

2.09

4.48

17.7

12.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

167

1.93

4.46

1.4

1.6

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.44

4.43

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

159

1.95

4.43

1.7

umol/l

0.7

0.01

126

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

367

1.61

4.42

3.6

3.1

umol/l

38.8

42.1

0.71

319

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

339

1.63

4.41

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

167

711

1.43

4.40

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

118

2.11

4.39

11.1

8.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

114

2.13

4.39

1.7

3.6

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

4.56

4.37

6.8

3.4

umol/l

89.0

92.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

173

1.90

4.34

1.4

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

390

1887

1.26

4.34

5.7

6.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

363

1742

1.27

4.33

1.3

umol/l

4.0

5.0

5.90

322

1611

(3012898) Urea [Moles/volume] in Urine

313

1.65

4.32

1.3

1.7

mmol/l

162.1

173.3

0.32

280

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

237

1902

0.76

4.27

1.7

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

173

746

1.41

4.26

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

144

601

1.46

4.23

7.0

5.8

68.9

70.9

0.38

102

486

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

120

2.08

4.22

1.1

u/l

310.6

455.3

0.51

105

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

206

1.80

4.19

2.0

2.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.19

4.12

1.1

1.2

nmol/l

245.9

271.0

0.30

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1943

10719

1.10

4.09

1.3

miu/ml

211.4

222.6

0.69

825

5005

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

177

1.85

4.08

1.1

u/field

1.4

1.1

0.66

116

(3036071) Salmonella sp Ab [Titer] in Serum

226

1027

1.34

4.06

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

139

1201

0.70

4.06

1.6

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

118

2.06

4.05

1.1

1.0

u/ml

0.0

0.1

1.51

(3036312) Salmon IgE Ab [Units/volume] in Serum

182

1.84

4.04

1.1

u/ml

1.3

1.5

0.08

132

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

165

1.88

4.02

1.0

u/ml

6.6

20.1

2.70

133

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2217

12327

1.10

3.98

1.7

1.6

mg/l

4.6

3.3

3.50

1691

8512

(3005011) Chlamydia sp Ab [Titer] in Serum

106

422

1.53

3.94

1.7

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

203

913

1.35

3.92

1.3

1.4

55.5

54.4

0.17

175

776

(3050794) Legionella sp Ab [Presence] in Serum

252

1.69

3.90

1.1

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

176

1.83

3.87

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

185

1.81

3.86

1.3

1.4

umol/l

83.6

79.9

0.31

169

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

190

1.79

3.83

1.1

1.3

u/ml

2.7

8.9

0.88

164

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

329

1.59

3.81

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

365

1783

1.24

3.80

1.3

1.4

mmol/l

5.9

5.6

3.02

349

1680

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.75

3.74

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

346

1.56

3.70

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.30

3.70

11.7

7.3

—

(3027944) Amphetamines [Presence] in Urine

2095

13864

0.92

3.69

2.5

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

232

0.37

3.69

1.1

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

127

1.96

3.68

1.2

1.1

mg/l

0.0

0.4

0.53

113

(3007456) Orange IgE Ab [Units/volume] in Serum

2.41

3.65

1.0

u/ml

0.0

0.2

0.64

(3013293) Extractable nuclear Ab [Presence] in Serum

112

462

1.47

3.56

1.7

1.6

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.32

3.52

11.2

7.6

44.7

43.3

0.08

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

209

1.72

3.52

1.0

u/ml

0.1

1.9

2.35

140

(40768795) Lymph node Pathology biopsy report

579

2989

1.18

3.45

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

215

1.70

3.45

1.1

1.0

u/ml

0.2

1.0

0.58

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

101

2.05

3.43

1.2

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

397

1981

1.22

3.43

11.6

12.3

mmol/l

0.6

1.26

358

1828

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

344

1.54

3.39

2.0

1.6

mg/l

1.4

1.7

2.06

293

(3013466) aPTT in Blood by Coagulation assay

194

1.72

3.35

1.1

35.2

37.5

2.35

163

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

748

3950

1.15

3.34

1.1

1.0

u/ml

0.5

0.04

202

834

(40763480) Human metapneumovirus Ag [Presence] in Specimen

137

1.86

3.29

1.6

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

104

1.99

3.20

1.4

nmol/l

423.1

516.0

0.46

104

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

432

2191

1.20

3.19

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

225

1.65

3.18

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

292

1.56

3.15

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6422

40726

0.95

3.15

2.2

2.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

129

561

1.40

3.15

1.5

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.23

3.14

3.7

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

102

425

1.46

3.14

1.2

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.34

3.07

1.3

1.5

nmol/l

145.3

140.7

0.04

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

338

1.51

3.06

1.5

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

216

1021

1.29

3.04

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

432

2203

1.19

3.03

1.2

—

(3022689) Creatine [Moles/volume] in Urine

184

853

1.31

3.00

1.4

1.5

—

(4133840)

194

906

1.30

3.00

1.2

—

(3027008) Opiates [Presence] in Urine

2152

14079

0.93

2.95

2.4

2.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

350

1755

1.21

2.94

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

391

1.46

2.94

1.0

—

(3032641) Amino acids panel - Urine

2.93

2.94

1.2

1.3

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.93

2.94

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

143

1.78

2.92

1.2

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5423

34459

0.95

2.90

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

318

1.51

2.90

2.9

mg/l

1.3

0.02

211

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.04

2.88

1.1

1.0

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.11

2.87

1.3

1.7

ug/l

142.1

115.4

0.22

(3027035) Albumin [Mass/time] in 24 hour Urine

285

1.53

2.86

1.2

1.4

mg/24h

824.2

253.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

271

1.55

2.83

1.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

214

1.62

2.82

2.3

3.0

pmol/l

89.8

364.3

0.39

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

847

4569

1.13

2.82

1.3

mmol/l

7.2

7.1

0.14

615

3297

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

153

698

1.33

2.82

1.2

1.3

—

(3049233) Organic acids panel - Urine

2.63

2.80

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

243

1180

1.25

2.79

1.3

1.5

74.7

72.6

1.73

228

1124

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.28

2.78

2.5

2.3

mu/l

1.8

2.3

0.23

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

239

1159

1.25

2.77

1.3

1.5

mu/l

937.0

665.3

0.29

224

1103

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.23

2.77

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

2173

12281

1.08

2.76

1.7

1.6

mu/l

309.6

309.0

0.02

1978

11105

(3006567) Chloride [Moles/time] in 24 hour Urine

2.29

2.69

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

342

1729

1.20

2.68

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.15

2.68

1.1

g/l

0.4

0.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

273

1352

1.23

2.64

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

181

1.64

2.61

1.1

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.82

2.58

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

2170

14106

0.93

2.55

2.6

2.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

364

1861

1.19

2.55

1.0

u/ml

0.4

0.8

0.77

240

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

114

1.81

2.52

1.1

u/field

1.9

1.0

0.54

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.05

2.52

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

380

1.42

2.49

1.2

1.3

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.88

2.49

1.0

1.1

pmol/l

151.4

231.0

1.00

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

401

2075

1.17

2.45

2.0

1.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

205

993

1.25

2.45

1.2

1.3

22.2

20.9

0.07

174

(3033086) Enterovirus NOS Ab [Titer] in Serum

102

1.85

2.44

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.02

2.44

1.0

u/ml

0.1

0.08

(3000764) Benzodiazepines [Presence] in Urine

2157

13991

0.93

2.40

2.5

2.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

118

952

0.75

2.40

2.6

3.0

—

(3003694) ABO and Rh group [Type] in Blood

15421

91617

1.03

2.40

1.4

1.5

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.58

2.39

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

241

1193

1.23

2.38

1.2

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

113

507

1.35

2.38

1.5

1.4

nmol/l

0.2

0.26

357

(3032743) Legionella sp IgG Ab [Presence] in Serum

201

1.57

2.35

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

117

1.77

2.34

1.8

1.3

—

(3011288) Drugs identified in Urine by Screen method

1641

9243

1.08

2.34

3.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.09

2.32

1.1

1.0

g/l

0.1

0.0

0.38

(3018291) Platelet Ab [Presence] in Serum

2.29

2.32

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

100

1.82

2.29

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1725

11250

0.93

2.27

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.84

2.26

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1763

11488

0.93

2.26

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

415

2170

1.16

2.26

17.6

18.6

nmol/l

1389.6

2916.7

1.05

391

2080

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.40

2.24

1.0

—

(3041184) Isoniazid [Presence] in Urine

2.55

2.18

2.9

2.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

210

1.53

2.17

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2121

12096

1.07

2.16

2.0

1.8

—

(3017400) Magnesium [Moles/volume] in Urine

2.10

2.14

1.1

mmol/l

3.3

2.8

0.27

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

149

1.63

2.12

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

352

1.40

2.11

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

315

2243

0.85

2.06

1.3

g/l

1.5

0.14

124

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.10

2.04

5.2

3.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

132

623

1.29

2.02

1.3

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.96

2.01

1.3

1.1

—

(3036180) Methadone [Presence] in Urine

1.96

2.01

5.0

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

327

1697

1.17

2.01

2.3

1.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

132

625

1.28

1.97

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

132

625

1.28

1.97

1.3

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

181

1.54

1.97

1.1

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.02

1.97

2.1

2.2

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.06

1.96

1.0

umol/l

402.8

352.7

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.75

1.93

1.1

1.0

u/ml

0.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

128

606

1.28

1.93

1.1

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.54

1.92

1.1

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.54

1.92

1.1

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.86

1.91

1.0

1.1

u/field

1.5

1.3

0.21

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2326

13365

1.06

1.90

2.3

u/l

5539.2

5655.5

0.06

763

5361

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.82

1.88

1.1

—

(3020650) Glucose [Presence] in Urine

174

859

1.23

1.85

1.6

1.4

—

(3027874) Urate [Moles/volume] in Urine

1.74

1.85

1.0

1.1

mmol/l

1.8

8.7

0.50

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

389

2064

1.15

1.81

12.8

13.2

nmol/l

817.7

1314.3

0.52

373

1996

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.73

1.81

1.6

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

210

1.48

1.81

2.5

2.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.02

1.78

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

191

1.49

1.78

1.1

1.4

—

(3024316) Viscosity of Plasma

143

1.57

1.74

1.8

1.7

mpas

1.7

0.01

(40768793) Breast Pathology biopsy report

1219

6886

1.08

1.71

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

195

1.46

1.63

1.4

1.3

umol/24h

366.4

321.4

0.54

195

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.81

1.57

1.0

u/ml

1.9

0.5

0.52

(3042628) Porphyrins [Moles/volume] in Urine

3.80

1.57

1.2

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

189

960

1.20

1.57

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.72

1.55

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.70

1.53

1.3

1.1

mmol/l

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

183

1.46

1.53

1.0

1.1

u/ml

2.2

7.7

3.64

129

(3006598) pH of Arterial cord blood

166

0.55

1.50

1.2

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

276

1.36

1.49

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5877

36721

0.97

1.46

2.1

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

173

880

1.19

1.44

1.3

1.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.28

1.38

1.1

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

924

6029

0.93

1.37

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

121

0.50

1.35

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

297

1587

1.14

1.34

5.6

6.2

u/ml

179.4

3436.3

1.01

333

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

129

1.51

1.32

1.4

1.3

u/field

1.1

0.13

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.60

1.32

2.2

2.0

—

(3043614) Bacteria identified in Aspirate by Culture

3.04

1.30

1.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

3.04

1.30

2.4

1.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.78

1.30

1.0

1.1

3.3

2.3

0.40

(3046861) Legionella sp Ag [Presence] in Urine

160

1.44

1.28

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

628

0.79

1.27

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

342

2324

0.89

1.26

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.57

1.23

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

167

1.42

1.22

1.2

2.3

mmol/l

22.4

18.6

0.76

140

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.97

1.22

1.1

1.0

u/ml

0.3

0.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

481

0.77

1.21

1.1

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.79

1.17

1.0

1.1

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.50

1.16

1.0

1.1

umol/l

27.7

30.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

194

1019

1.16

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

266

1429

1.13

1.15

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.65

1.14

5.3

mmol/l

0.3

0.2

0.14

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

154

1.42

1.14

1.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.81

1.14

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.57

1.08

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.57

1.08

1.4

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

347

1.26

1.07

2.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

489

1.22

1.07

1.4

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

172

1.38

1.06

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

141

0.60

1.06

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

214

1.33

1.06

1.0

u/ml

0.3

0.8

1.80

123

(3017509) Phencyclidine [Presence] in Urine

392

1.24

1.04

2.1

1.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

220

0.69

1.03

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

2056

12986

0.96

1.02

2.6

2.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

824

5327

0.94

1.01

1.5

1.4

nmol/l

0.4

0.11

640

4155

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

197

0.68

1.00

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

133

1.42

1.00

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

357

1.24

0.98

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.43

0.97

1.0

1.1

umol/l

20.8

12.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.82

0.96

1.0

—

(3045177) Copper [Moles/volume] in Urine

1.70

0.96

1.0

1.1

umol/l

0.5

0.4

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.28

0.94

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.28

0.94

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1171

6768

1.05

0.93

4.3

3.1

mg/l

26.6

26.8

0.08

709

4290

(40758292) HTLV I+II Ab panel - Serum

102

521

1.19

0.91

1.4

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

2.14

0.90

1.8

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

694

3960

1.07

0.88

1.3

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.02

0.86

1.3

1.0

—

(3022725) Serotonin [Moles/volume] in Serum

107

1.42

0.84

1.4

1.5

nmol/l

906.6

884.1

0.03

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.65

0.81

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

350

1.21

0.81

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.49

0.80

1.0

g/l

160.2

163.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

267

1474

1.10

0.79

1.6

1.8

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.34

0.79

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

194

1.28

0.76

1.6

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.17

0.76

1.2

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.17

0.76

1.2

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.57

0.75

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.54

0.75

1.5

1.3

u/field

0.5

0.7

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.85

0.74

1.0

—

(3007463) Buprenorphine [Presence] in Urine

142

1.33

0.73

9.5

7.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

111

586

1.15

0.71

1.5

1.9

ug/l

1.9

3.7

1.17

366

(3007919) Fasciola sp Ab [Titer] in Serum

1.55

0.71

1.3

1.0

—

(3001556) Androgen free Index in Serum or Plasma

340

1.20

0.69

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

197

1.26

0.69

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1505

8823

1.04

0.69

1.9

1.7

—

(3025130) Human papilloma virus identified in Specimen

743

4746

0.95

0.69

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

187

1.27

0.68

1.0

—

(36303858) Crystals [Presence] in Urine

1.58

0.67

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2932

17380

1.03

0.66

1.4

1.3

iu/l

27.7

27.9

0.12

2513

15011

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.32

0.65

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.58

0.64

3.7

7.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

200

1.25

0.63

1.6

1.4

—

(3001729) Color of Synovial fluid

239

1.22

0.62

1.4

1.6

—

(3009754) Celery IgE Ab [Units/volume] in Serum

1.57

0.60

1.0

u/ml

0.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

1.82

0.60

1.3

1.9

—

(3034614) HLA Ag [Interpretation]

1.41

0.60

1.5

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

330

1.18

0.59

1.9

2.5

—

(40759632) Porphyrins [Mass/mass] in Stool

1.52

0.58

1.0

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.52

0.58

1.3

1.4

—

(3020618) Glucose [Moles/volume] in Synovial fluid

100

1.34

0.57

1.0

mmol/l

5.8

5.1

0.27

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

105

719

0.89

0.57

2.4

2.7

ng/l

109.6

105.6

0.09

370

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.56

0.56

2.8

2.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

400

1.15

0.55

6.5

9.3

umol/l

0.4

0.3

0.24

363

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

755

4393

1.04

0.55

1.6

1.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.58

0.54

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.48

0.54

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.48

0.54

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.48

0.54

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.48

0.54

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.48

0.54

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.48

0.54

2.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.33

0.53

1.0

u/ml

0.0

0.1

0.24

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

216

1.21

0.53

3.9

4.8

—

(3003338) MCHC [Mass/volume]

46511

281684

1.01

0.51

26.1

15.7

g/l

331.7

332.8

114.65

46188

279399

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

206

1.21

0.51

1.3

1.6

14.5

12.3

0.21

143

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

504

2912

1.05

0.51

3.7

3.8

u/ml

43.9

47.8

0.17

492

2882

(3051101) Glucose [Moles/volume] in Cord blood

532

0.88

0.50

5.4

5.6

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.46

0.50

1.0

ng/l

8064.0

12260.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.52

0.49

1.6

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

141

781

1.10

0.47

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

334

1.15

0.45

7.7

7.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.69

0.44

1.0

1.2

nmol/24h

19.0

33.2

—

(3007147) Virus identified in Stool by Electron microscopy

1.69

0.44

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

171

1.21

0.44

1.0

u/ml

0.5

12.5

0.50

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.39

0.43

1.0

u/ml

0.3

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.39

0.43

1.2

1.1

nmol/24h

80.0

100.8

0.84

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.43

0.43

1.1

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.43

0.43

1.1

1.4

—

(4038314)

227

0.83

0.43

1.1

1.2

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.43

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

146

962

0.92

0.42

1.8

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

123

1.23

0.40

1.3

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

162

1.20

0.40

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

118

1.24

0.39

1.0

u/ml

0.2

0.5

0.79

(1001926) Buprenorphine [Presence] in Urine by Screen method

1804

10731

1.02

0.38

2.7

2.3

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.39

0.38

2.8

2.4

umol/l

35.6

38.3

0.35

(3009992) Blasts/100 cells in Bone marrow

1.52

0.37

1.5

1.8

26.3

15.9

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.35

0.34

1.0

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

240

1.14

0.32

1.3

1.5

36.9

37.9

0.05

152

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.29

0.32

2.6

6.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

127

1.20

0.32

1.8

1.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.26

0.32

1.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.34

0.31

1.1

1.3

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

288

1.12

0.30

1.5

1.2

mmol/l

21.6

20.9

0.48

232

(3029612) Listeria sp Ab [Titer] in Serum

0.74

0.30

1.3

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

202

1.14

0.29

1.1

1.3

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

123

1.19

0.28

1.0

u/ml

0.1

0.3

0.54

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

528

1.08

0.28

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

131

748

1.06

0.26

1.1

mg/g

7.1

6.8

0.16

124

710

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.19

0.23

5.9

5.6

mg/l

1.1

1.5

0.76

(3007700) Barley IgE Ab [Units/volume] in Serum

155

1.14

0.22

1.0

u/ml

0.3

9.8

0.52

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.22

0.0

2.7

—

4.1

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.22

0.0

7.1

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

712.5

—

(3013762) Body weight Measured

127

1.15

0.21

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

826

4920

1.02

0.21

3.5

3.6

u/ml

31.3

37.5

1.01

791

4748

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

179

1.12

0.21

1.3

1.4

2.4

1.5

0.31

114

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.21

0.20

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.18

0.19

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

188

1187

0.96

0.19

2.5

2.4

nmol/l

144.1

150.9

0.31

162

1030

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

298

1.08

0.18

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

239

0.91

0.17

1.1

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

451

0.94

0.16

2.3

2.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

108

1.12

0.14

1.0

u/ml

0.3

1.1

0.64

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.13

0.12

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

313

1939

0.98

0.11

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

449

2684

1.02

0.11

1.4

1.3

pmol/l

79.4

115.1

0.52

179

849

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.14

0.09

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

129

1.08

0.09

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

421

1.04

0.09

10.3

7.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

207

1.06

0.08

1.5

1.7

1.1

0.6

0.41

157

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

218

0.95

0.08

1.0

—

(3003577) Lead [Moles/volume] in Blood

256

1.04

0.07

1.1

1.5

umol/l

0.1

0.2

—

(40768800) Prostate Pathology biopsy report

951

5738

1.01

0.06

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8810

53586

1.00

0.05

1.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

409

1.02

0.04

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

909

5543

1.00

0.03

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

176

0.97

0.02

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

401

0.98

0.02

1.8

mmol/l

6.9

7.5

0.65

144

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

473

0.99

0.01

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

911

5539

1.00

0.00

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

207

1.00

0.00

6.3

2.6

13.9

12.6

0.10

(40758358) Immune stain study

140

1.00

0.00

1.0

—

(3013862) HLA-DP [Type]

126

1.01

0.00

1.0

—

(3022670) pH of Venous cord blood

0.98

0.00

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

125

1.02

0.00

1.0

—

(46236302) HLA-C [Type] by High resolution typing

125

1.02

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

125

1.02

0.00

1.0

—

(3022475) Manganese [Moles/volume] in Blood

211

1.01

0.00

1.2

1.3

—

(40763590) HLA-DQ beta [Type]

124

0.98

0.00

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

154

0.99

0.00

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

197

1.02

0.00

1.2

1.1

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.97

0.00

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.91

0.00

1.2

1.1

mmol/24h

170.3

138.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.96

0.00

1.0

1.1

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.0

3.8

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.93

0.00

1.2

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OESSTODUO and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OESSTODUO	1.359 [1.26, 1.46]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.152

During the follow-up period (1.1.1998 — 31.12.2019), 55226 out of 243683 females with K11_OESSTODUO died.

Males

Parameter	HR [95% CI]	p-value
K11_OESSTODUO	1.687 [1.56, 1.82]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 59241 out of 206058 males with K11_OESSTODUO died.

Mortality risk

Mortality risk for people of age

years, who have K11_OESSTODUO.

N-year risk	Females	Males
1	0.13%	0.279%
5	0.673%	1.655%
10	1.7%	3.874%
15	3.286%	7.238%
20	5.861%	12.319%

Relationships between endpoints

↥

Index endpoint: K11_OESSTODUO – Diseases of oesophagus, stomach and duodenum

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of oesophagus, stomach and duodenum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints